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A major focus of my work has been to understand the mechanism/s of sepsis 
development during respiratory bacterial infections with the goal of identifying novel 
alarmins/alarmin receptors. Specifically, I have analyzed the role of C-type lectins as 
novel alarmin/alarmin receptors likely involved in the development of sepsis resulting 
from acute pulmonary infection with Gram negative bacteria Francisella novicida and 
Klebsiella pneumonia (Kpn). In that regard, the first project was built upon a previous 
observation, made by Dr. Sharma, that two soluble lectins galectin-3 and -9 were 
upregulated and released in extracellular milieu in lungs of mice upon pulmonary 
infection with Francisella novicida (Fn). As alarmins are endogenous molecules released 
from dead/dying cells under pathological conditions, we wanted to examine if galectin-3 
and -9 act as alarmins to exacerbate the inflammatory response during Fn infection.  I 
was brought in as a co-author on the studies with galectin-3 where I examined the effect 
of this lectin on myeloid cell activation. My work showed that pre-treatment of primary 
neutrophils and macrophages with recombinant galectin-3 augmented Fn-induced 
activation of these cells in terms of increased reactive oxygen species and inflammatory 
cytokine production. Together with improved lung architecture, reduced cell death and 
improved survival of galectin-3
-/-
 mice in comparison with the wild-type mice , these 
findings suggested  that galectin-3 functions as an alarmin by augmenting the
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 inflammatory response in sepsis development during pulmonary Fn [1]. Similar studies 
with galectin-9 showed that galectin-9 also acts an alarmin during Fn infection-induced 
sepsis [2].  In the second project, we specifically examined the function of Clec4d, a 
mammalian C-type lectin receptors (CLRs) as possible alarmin receptor in the 
development of Gram-negative pneumonic sepsis caused by KPn. In our initial analysis, 
we found that this CLR was upregulated in the lungs of mice infected with KPn. In our 
follow up studies we observed a protective role of this receptor in pneumonic sepsis. In 
my paper as the first author we showed that Clec4d
-/-
 mice have an increased 
susceptibility to KPn infection, increased bacterial burden in systemic organs as well as 
blood, increased lung pathology as evident by increased accumulation of Ly6G+/CD11b+  
neutrophils and hyperinflammatory response [3]. While we observed no defect in 
bacterial phagocytosis in the absence of Clec4d, we found a possible role of Clec4d in 
turnover of neutrophils by efferocytosis.  In another paper that I co-authored as second 
author, we showed a protective role of another CLR Mincle. In this study I was primarily 
involved in demonstrating the increased susceptibility of Mincle
-/-
 mice to KPn 
pneumonia by reduced survival, increased bacterial burden and hyperinflammatory 
response [4]. On the basis of these findings, further studies are currently ongoing in 





Sepsis and Pneumonia: Healthcare burden and treatment 
A precise estimation of the number of cases in the US has been difficult partly due to the 
heterogeneity of the disease and the methodology used. Regardless of the range of 
estimated cases (256,000-750,000 annually in the US) and the associated mortality 
(28.6%-37.7%) reported [5-8], one thing is clear: despite decades of dedicated research 
efforts, occurrence of sepsis and septic shock has increased significantly over the past 
two decades. An accurate estimation of the disease incidence and mortality is critical for 
proper distribution of health care resources and a consistent definition of this complex 
disorder would help identify sepsis cases uniformly. Hence the American College of 
Chest Physicians and Society for Critical Care Medicine defined sepsis, severe sepsis, 
and septic shock as a disease complex with varying degrees of organs dysfunction  
resulting from a host response to systemic infection [9-11]. As a result of this uniform 
definition, sepsis has been recognized as a major US healthcare burden and according to 
Centers for Disease Control and Prevention,  it is the 11
th
 leading cause of deaths in the 
US, and the leading cause of non-coronary deaths in ICU patients [12,13]. Moreover, 
severe sepsis, defined as sepsis associated with organ dysfunction and hypoperfusion/ 
hypotension with extremely high ICU admission rate has been estimated to cost the U.S. 
healthcare system $24.3 billion in 2007 [14]. A mortality rate of approximately 50% is
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 associated with septic shock, which is highly unacceptable [5]. Individuals at the highest 
risk of developing sepsis or severe sepsis include older adults of over 65 years of age, 
patients with chronic disease conditions such as cancer, diabetes, chronic obstructive 
pulmonary disease, chronic liver or kidney diseases and individuals with abnormal 
immune response to infections [15,16].  
Respiratory tract infections and pneumonias are the most common cause of sepsis 
(accounting for almost 50% of all sources of infections) and are associated with highest 
mortality rates [15,17] . Despite a recent increase in the numbers of Gram positive 
bacterial infection cases, Gram negative infections remain the cause of the highest 
mortality [18,19].  Interestingly, a recent study found that a lung infection was more 
commonly the primary cause of sepsis in patients with a negative culture than in patients 
with a positive culture [20]. This may indicate the critical need for biomarkers and 
improved methodologies for detection and prognosis of pneumonia. Gram negative 
bacteria belonging to Enterobacteriaceae family (e.g. E.coli and Klebsiella species) are 
the most common causes of sepsis [21,22]. 
Despite continuous and dedicated research on sepsis (a total of 139,200 Pubmed entries 
with the keyword “sepsis”; first article published in 1886), and hundreds of clinical trials, 
we are still ways from finding a treatment for this deadly disorder. This may partly be 
due to the complexity of this disease and the fact that immune regulatory processes 
controlling sepsis are not completely understood. Due to the overactivation of pro-
inflammatory cascades occurring during a microbial infection, the initial attempts to treat 
sepsis centered around dampening or blockage of inflammatory cytokines (reviewed in 
[23]).  Due to its central position in auto-and paracrine loops of numerous inflammatory 
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mediators, tumor necrosis-α (TNF-α) has been the target of most anti-cytokine therapies 
which have failed in clinical trials [24,25]. We have come a long way since the 
recognition of “cytokine storm or hypercytokinemia”; a condition of co-existence of both 
pro- and anti-inflammatory cytokines. Moreover, with strong evidence of the complexity 
of sepsis, characterized by a cross-talk between multiple biological systems (reviewed in 
[26]), it is now clear that targeting a single biomolecule is highly unlikely to provide cure 
for heterogeneous sepsis patient population. For a number of years, recombinant 
activated protein C was the only FDA approved drug for sepsis treatment that targeted 
disseminated intravascular coagulation (DIC)”, a major complication of sepsis. However, 
in October 2011, this drug (Xigris) was withdrawn from market following the much 
anticipated results of the clinical trial (PROWESS-SHOCK) where it failed to show any 
survival benefit for severe sepsis and septic shock patients [27]. This underscores the 
need for a better understanding of immune dysfunction that will likely identify novel 
targets for successful treatment of this disorder. 
Inflammatory Mechanisms in sepsis: Role of alarmins 
Sepsis is mainly characterized by an imbalanced, hyper-inflammatory response to an 
infection. As for any pathogenic insult, innate immune components play pivotal role in 
initiating the pro-inflammatory response required to combat infection. The key players in 
this process are host Pattern Recognition Receptors (PRRs) and pathogen-associated 
molecular patterns (PAMPs). Three families of host PRRs involved in the recognition of 
PAMPs are Toll-Like Receptors (TLRs), NOD-Like receptors (NLRs) and RIG-I like 
receptors (RLRs). Regardless of the origin of PAMPs or the localization of PRRs, their 
interaction results in an inflammatory response that serves as a first line of defense 
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against a wide variety of pathogens (Reviewed in [28]). On the flip side, the non-
specificity of innate immune response and the antimicrobial mediators produced by the 
first responder cells such as neutrophils can result in severe damage to by-stander cells at 
the site of acute inflammation. This causes the release of endogenous host factors in the 
extracellular milieu. These endogenous molecules are termed alarmins, and typically 
perform homeostatic functions when contained within cellular compartments. However 
under pathological conditions, these molecules can be released either passively from dead 
cells or actively via non-classical secretion pathways. Once in the extracellular milieu, 
they exhibit immune modulatory properties such as induction of pro-inflammatory 
cytokines, immune cell chemotaxis and regulation of cell death [29,30]. The interaction 
of Toll-Like receptors (TLRs) as well as NOD-Like receptors (NLRs) with pathogen 
derived PAMPs during sepsis has been studied extensively (reviewed in [28,31]. 
However, the recognition of self-molecules (alarmins) by signaling receptors and the 
concomitant inflammatory response is an area of research which is still in its infancy. The 
role of several alarmins such as High Mobility Group Box 1 (HMGB1) and S100 family 
of calcium binding proteins has been demonstrated in various inflammatory conditions 
[32,33]. However, in a complex immune disorder like sepsis which is an interplay of 
several host immune pathways such as the coagulation system, complement cascade and 
even the autonomic nervous system, it is likely that several alarmins are involved at the 
intersections of these pathways. Thus, identification of novel alarmins and their receptors 
may aide in understanding this complex disorder and may present additional targets for 
effective therapeutics. Moreover, depending upon the type of infectious insults detected 
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in septic patients, the identification of these alarmins and alarmin receptors may present 
opportunities to customize the treatment options in septic patients.  
Resolution of inflammation 
Once the pathogenic insult has been taken care of, it is imperative that the immune cells 
are cleared off the mileau, in order to restore the quiescent state of homeostasis. This is 
achieved by the process of efferocytosis, where the innate immune cells such as 
neutrophils, once they have completed their task of combating pathogens, start to undergo 
apoptosis and are eventually phagocytosed by professional phagocytes in the vicinity 
[34].  Deregulation of this process can result in secondary necrosis of these apoptotic 
cells causing the release of host alarmins in the extracellular milieu which, we now know, 
play an important role in exaggeration of an ongoing inflammation [35,36]. As sepsis is 
often characterized by massive cell death in systemic organs, it is tempting to speculate 
that a deregulation of efferocytosis process and turnover of neutrophils contributes to 
sepsis development. However, studies correlating these two processes with sepsis are 
surprisingly few. In addition to clearing dead cell carcasses, the process of efferocytosis 
also modifies the phenotype of phagocytic cells from inflammatory to anti-inflammatory 
nature resulting in production of host mediators such as TGF-beta and IL-10 that not only 
shut the inflammatory response but also inhibit further influx of immune cells [37]. All of 
these events constitute the complex process of resolution. In contrast to an initial belief of 
resolution of inflammation being a passive process resulting from mere dilution of 
chemokine gradients over time causing a cessation of cellular recruitment to the site of 
injury, recent studies have revealed that the resolution of inflammation is a well-
orchestrated active process [38]. Deficiency in any of its components may lead to over-
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active, uncontrolled chronic inflammation. It is thus tempting to assume that, in the 
context of an inflammatory disorder such as sepsis, this regulated process of resolution is 
disrupted and progresses towards an accelerated and sustained condition of chronic 
inflammation. This is an area of investigation which may hold some key answers to 
queries regarding the mechanisms of sepsis development and how an otherwise beneficial 
host response turns to a harmful process of excessive inflammation and overt tissue 
destruction. 
C-Type Lectins: Role in inflammation and resolution  
Innate C-type lectins are emerging as immune determinants that can shape the balance 
between inflammation and homeostasis. These are Ca
++
 dependent glycan-binding 
proteins that share a homologous carbohydrate-recognition domain. With over 1000 
members, the C-type lectin superfamily includes secreted as well as transmembrane 
proteins. Most commonly expressed on the cells of myeloid origin, C-type lectin 
receptors (CLRs) detect the PAMPs on microbes and, unlike TLRs, phagocytose the 
microbes, leading to activation of tyrosine kinases which in-turn coordinate multiple 
downstream signaling pathways leading to myeloid cell activation [39-41]. This has 
implications not only for clearance of the internalized microbes via phagolysosomal 
pathway and generation of innate immune mediators, but also for processing and 
presentation of antigens to activate the adaptive immune system [42-44]. While in most 
instances, this pathogen-binding capacity, internalization and signaling by CLRs 
mediates host defense against infection, there is evidence that myeloid CLRs can be 
exploited by pathogens to evade or suppress the immune response [45,46]. Beyond 
pathogen binding, accumulating evidence now suggests that many CLRs can bind to 
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endogenous or self-molecules from damaged/altered cells, thus acting as sensors of injury 
or cellular stress. For example, Mincle (Clec4e), a dectin-2 family CLR recognizes 
SAP130, an alarmin released from damaged cells causing activation of inflammatory 
response [47,48]. While Mincle has been shown to act in concert with another Dectin-2 
family CLR Clec4d in recognition of mycobacterial PAMP and activation of 
inflammatory response [49], the role of Clec4d in Mincle-mediated recognition of 
alarmin SAP130 is unknown.  MGL-1 and Lox-1 have been shown to bind to and 
internalize aged and apoptotic cells [50,51]. These CLRs thus have been speculated to 
play a role maintaining homeostasis. Furthermore, DC-SIGN and MGL have been shown 
to bind tumor antigens and possibly contribute to tumor surveillance [52,53]. Mannose 
receptor plays a role in clearance of mannosylated proteins from serum [54]. Apart from 
membrane-bound CLRs, many soluble C-type lectins such as Collectins (Collagenous 
Lectins) have also been shown to engage in recognition and clearance of apoptotic cells 
[55-57]. The outcome of this interaction however, varies depending upon the tissue type 
and the interacting proteins. For example, surfactant proteins in the immune-privileged 
tissues such as lungs can opsonize and facilitate clearance of cellular material such as 
DNA without evoking an immune reaction [58]. Involvement of complement proteins in 
this soluble lectin mediated opsonization and phagocytosis, however, results in an 
inflammatory response [59,60]. Despite these pleotropic functions in balancing the 
inflammation and homeostasis, the role of CLRs in sepsis, a dynamic disease marked 





Another family of soluble lectins that has emerged as pleotropic regulators of immune 
responses are Galectins (β-galactoside binding lectins). These are one of the most 
ubiquitously expressed lectins which regulate a variety of inflammatory and homeostatic 
processes such as cell growth, proliferation, cell-cell interaction, acute and chronic 
inflammation and immune tolerance [61-63]. Interestingly, consistent with the property 
of alarmins, galectins can be released by “leaderless”, non-classical secretion pathway 
and play homeostatic roles in regulation of cell cycle and apoptosis, phagosome 
formation and stabilization of intracellular signalling when contained in intracellular 
compartments, but display inflammatory and T cell apoptotic activities upon extracellular 
release [63,64].  Moreover, the extracellular release of galectins seems to correlate with 
the virulence of invading pathogen [65], as well as influences immune responses through 
chemotaxis and activation of innate immune cells [66]. Despite the progress in our 
understanding of inflammatory properties of galectins, the role of these lectins as 
alarmins in the development of sepsis disorder has not been studied.    
Central Hypothesis 
In light of these pleotropic immune regulatory functions of CLRs, the central hypothesis 
of my dissertation proposal is that C-type lectin receptors regulate inflammatory response 
in pneumonic sepsis by functioning as alarmins (soluble lectins) and alarmin receptors 
(cell-surface CLR). Before joining my lab, a large scale screening of over 200 soluble 
and membrane-bound CLRs in the lungs of mice undergoing pneumonic sepsis revealed 
upregulation of several of these molecules at transcript level. My project involved 
examination of the function of two soluble lectins Galectin-3 and -9 as putative alarmins 
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and two membrane-bound lectins Mincle and Clec4d as putative alarmin receptors in 
pneumonic sepsis.  
Animal Models of Sepsis  
Various animal models of sepsis have contributed significantly to our understanding of 
host response and inflammatory cascade in the pathogenesis of sepsis. Endotoxemia 
model developed by bolus injection of LPS mimics pathophysiological alterations 
reported in sepsis patients to some extent, but the rapid and transient increase in 
inflammatory cytokines in this model differs from a prolonged systemic response 
observed in sepsis patients [67,68]. In fact it has been difficult to extrapolate the findings 
of many endotoxin mouse models (cecal ligation puncture, colon ascendens stent 
peritonitis) due to a relative resistance of mice to endotoxin shock in comparison with 
humans [69-71]. We chose to utilize pneumosepsis model of pulmonary bacterial 
infection because lung infections are a major source of sepsis in humans [72]. This model 
produces detectable bacteremia, systemic organ damage and mortality with severe lung 
pathology, observed in human patients. Two bacterial pathogens that we have used in our 
studies are Klebsiella pneumoniae (KPn) and Francisella novicida (Fn). Pulmonary 
infection of C57/BL6 mice with these pathogens causes bacteremia, extensive cell death 
leading to sever lung pathology, hypercytokinemia and systemic organ dysfunction.  The 
excessive cell death is a hallmark of these pulmonary bacterial sepsis model infection, 
regardless of the bacterial strain used [73] additionally, Dr. Sharma’s previous studies 
showed Francisella infected phagocytes defective in efferocytosis, resulting in 
accumulation of dead cells and their contents in the milieu [74].  We thus hypothesize that 
during pneumosepsis host cells undergo death due to bacterial replication and 
10 
 
inflammatory response. Membrane-bound CLRs such as Clec4d and Mincle play a 
protective role by mediating clearance of dead cells by phagocytes. On the other hand, 
galectins released from dead cells play a pathogenic role and function as alarmins to 
activate myeloid cells causing them to secrete proinflammatory mediators and 
exacerbation of inflammatory response culminating in sepsis.  
11 
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Sepsis is a complex immune disorder with a mortality rate of 20-50% and currently has 
no therapeutic interventions. It is thus critical to identify and characterize 
molecules/factors responsible for its development. We have recently shown that 
pulmonary infection with Francisella results in sepsis development. As extensive cell 
death is a prominent feature of sepsis, we hypothesized that host endogenous molecules 
called alarmins released from dead or dying host cells cause a hyper inflammatory 
response culminating in sepsis development. In the current study we investigated the role 
of galectin-3, a mammalian β-galactoside biding lectin, as an alarmin in sepsis 
development during F. novicida infection.  We observed an upregulated expression and 
extracellular release of galectin-3, in the lungs of mice undergoing lethal pulmonary 
infection with virulent strain of F. novicida but not in those infected with a non-lethal, 
attenuated strain of the bacteria. In comparison with their wild-type C57Bl/6 
counterparts, F. novicida infected galectin-3 deficient (galectin-3
-/-
) mice demonstrated 
significantly reduced leukocyte infiltration, particularly neutrophils in their lungs. They 
also exhibited a marked decrease in inflammatory cytokines, vascular injury markers and 
neutrophil associated inflammatory mediators. Concomitantly, in-vitro pre-treatment of 
primary neutrophils and macrophages with recombinant galectin-3 augmented F. 
novicida-induced activation of these cells. Correlating with the reduced inflammatory 
response, F. novicida infected galectin-3
-/-
 mice exhibited improved lung architecture 
with reduced cell death and improved survival over wild-type mice, despite similar 
bacterial burden.  Collectively, these findings suggest that galectin-3 functions as an 
13 
 
alarmin by augmenting the inflammatory response in sepsis development during 





Sepsis results in 750,000 hospitalizations every year in the US and is the second leading 
cause of mortality in patients admitted to intensive care units [75]. Pulmonary infections, 
in turn, are a major cause of sepsis [76]. However, the mechanisms responsible are not 
well understood. This is underscored by a lack of effective therapeutics against this 
immune disorder despite more than two decades of active research. Our recent studies 
have shown that pulmonary infection of mice with fully virulent Francisella tularensis as 
well as the murine model organism F. novicida (F.n.) a Gram negative bacterial 
pathogen, leads to development of severe sepsis characterized by hyperinflammation, T 
cell depletion, and extensive cell death in systemic organs [73,77,78]. We are thus using a 
murine inhalation model of F.n. infection to understand the mechanism/s responsible for 
pulmonary infection-induced sepsis development.. Intriguingly, this pathogen is not 
known to produce any exotoxin, which can account for the lethality of this infection. 
Moreover, the lipid A of Francisella LPS does not stimulate TLR4 and is thus hypo-
inflammatory [79]. Studies from our and other laboratories have shown that extensive 
tissue damage and wide-spread cell death is a hallmark of Francisella infection, 
regardless of the bacterial strain [78,80-83]. Additionally, our studies show that 
Francisella infected macrophages are defective in clearance of dead cell debris, a process 
termed efferocytosis, leading to accumulation of these dead cells and their contents [74]. 
We thus hypothesized that in the absence of any bacterial toxins, host endogenous 
molecules released from these dead or dying cells contribute to the inflammatory 




 Alarmins are host endogenous factors which perform homeostatic functions when 
contained within cellular compartments [29]. However, under pathological conditions, 
these molecules can be released either passively from dead cells or actively via non-
classical secretion pathways [84]. Once in the extracellular milieu, they exhibit immune 
modulatory properties such as induction of pro-inflammatory cytokines, immune cell 
chemotaxis, and regulation of cell death [29,30,84]. The overt inflammation during sepsis 
is primarily a result of the interaction between innate immune receptors with pathogen 
derived molecules (Pathogen Associated molecular patterns (PAMPs) and alarmins. 
PAMPs and alarmins together constitute Danger-Associated Molecular Patterns 
(DAMPs). The interaction of Toll-Like receptors (TLRs) as well as NOD-Like receptors 
(NLRs) with pathogen derived PAMPs during sepsis has been studied extensively 
(reviewed in [26,31]. However, the recognition of self-molecules (alarmins) by signaling 
receptors and the concomitant inflammatory response is an area of research which is still 
in its infancy. Moreover, in a complex immune disorder like sepsis which is an interplay 
of several host immune pathways such as the coagulation system, complement cascade 
and even the autonomic nervous system [26], it is likely that several alarmins are 
involved at the intersections of these pathways. Thus, identification of novel alarmins 
may aide in understanding this complex disorder and may present additional targets for 
effective therapeutics. As sepsis developed during pulmonary infection with Francisella 
is associated with extensive cell death in lungs and other systemic organs, we sought to 





Galectins constitute a soluble mammalian β-galactoside binding lectin family which play 
homeostatic roles in regulation of cell cycle and apoptosis, as well as display 
inflammatory and immune modulatory activities in various pathological conditions 
[63,64,66,85]. Previous studies have implicated galectin-3 in regulation of various 
inflammatory conditions including endotoxemia and airway inflammation [86-88]. In this 
study we show that galectin-3, a mammalian galactoside binding soluble lectin is 
upregulated and released in lungs of mice undergoing lethal respiratory infection with 
F.n. but not in mice vaccinated with an attenuated mutant strain of the bacteria that 
protects these mice from an otherwise lethal challenge.  We thus hypothesized that 
galectin-3 exacerbates the inflammatory response during lethal infection.  The outcome 
of this study, with use of galectin-3 deficient mice, shows that galectin-3 plays the role of 
an alarmin in Francisella infection induced sepsis development.  
Materials and Methods 
Ethics Statement 
The animal usage protocols were approved by the Institutional Animal Care and Usage 
Committee at the University of North Dakota (protocol no. 1108-3) and the University of 
Texas at San Antonio (protocol no. MU066). All the procedures strictly followed the 






Bacterial strains and Mice 
The F.n. strain U112 and an attenuated transposon mutant lacking a 58kDa protein of 
hypothetical function (kindly provided by Dr. Larry Gallagher, University of 
Washington) were grown on Trypticase Soy Agar (TSA) medium supplemented with L-
cysteine at 37
o
C. After overnight growth, the bacteria were harvested and suspended in a 
freezing medium (250 mM sucrose, 10 mM sodium phosphate pH 7.2 and 5 mM 
glutamic acid). Stocks were aliquoted and frozen at -80
o
C for further use. 
 All in-vivo experiments were performed using 6-8 wk old female C57Bl/6 wild-type and 
galectin-3 
-/-
 mice. Galectin-3 
-/-
 mice were purchased from Jackson Laboratories (Bar 
Harbor, ME). Sex- and age-matched galectin-3
+/+
 mice with the same genetic background 
were used as control.  
Antibodies and Reagents  
All reagents were purchased from Sigma-Aldrich unless otherwise indicated. For 
detection of galectin-3 by immunofluorescence (IF) staining, a purified rat anti-mouse 
galectin-3 antibody (eBioscience, San Diego, CA) followed by Alexa-546 conjugated 
chicken anti-rat antibody (Molecular Probes, OR) was used.  A rat anti-mouse CD11b 
antibody conjugated to PE (BD Pharmingen) and a purified rat anti-mouse Gr1 
monoclonal antibody, clone Ly-6G (Clone Accurate Chemical, Westbury, NY, USA), 
followed by the secondary antibody RRX-conjugated Affipure goat anti-rat IgG (Jackson 
ImmunoResearch Laboratories, West Grove, PA, USA) were used for double staining of 
activated neutrophils. The terminal deoxyribonucleotidyl transferase-mediated 
triphosphate (dUTP)-biotin nick end labeling (TUNEL) staining kit was purchased from 
Chemicon International, CA. Purified recombinant galectin-3 was purchased from R&D 
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Systems, MN.  The endotoxin level was <1.0 EU per µg of protein. For detection of 
reactive oxygen species, Fc OxyBURST assay reagent was purchased from Molecular 
Probes, Eugene, OR. Mouse IL-6 and TNF-α ELISA kits (BD OptEIA) were from BD 
Biosciences, San Diego, CA.   
Infection of Mice, survival and bacterial burden   
Mice were anaesthetized with a mixture of ketamine HCL and xylazine (30mg/ml 
ketamine, 4 mg/ml xylazine in PBS) and were infected intranasally with 50-70 CFUs of 
the wild-type F.n.  
strain U112 in 20 μl of PBS or with 20 µl of PBS alone. Mice were monitored daily for 
signs of disease, which typically included piloerection, hunched gait, lethargy and eye 
discharge. The survival of infected mice was recorded for up to 2 weeks post-infection 
(p.i.). Mice displaying severe signs of distress (labored breathing, non-responsiveness to 
cage tapping, failure of grooming and severe eye discharge) were humanely sacrificed by 
injecting a mixture of ketamine (90-120mg/kg) and xylazine (10mg/kg) followed by 
cervical dislocation. The death was recorded as tularemia induced mortality.  For non-
lethal infection, the mice were similarly inoculated with the mutant bacteria followed 3 
weeks later by challenge with similar dose of the wild-type organisms. In some 
experiments, the mice were euthanized  at 3 days p.i. and blood, lungs and liver were 
aseptically harvested. The organs were homogenized aseptically in cold PBS with 
Complete
TM 
protease inhibitor cocktail (Roche Diagnostics, Germany). For the bacterial 
burden analyses, the homogenates and blood were serially diluted in PBS and plated on 







Quantitative real-time PCR 
Lungs from infected and mock control mice at various times post-infection were 
immediately removed after perfusion and total RNA was extracted using Trizol reagent 
(Invitrogen) according to the manufacturer’s instructions. Real-time PCR analysis of the 
samples was performed using SYBR green (Applied Biosystems, CA, USA) as the 
detection dye to measure the expression levels of Galectin-3-specific mRNAs. Briefly, 
one microgram of total RNA from either infected or mock infected mice was reverse 
transcribed into cDNA by using a high capacity cDNA reverse transcription kit according 
to the manufacturer’s instructions (Applied Biosystems, CA, USA). Transcript levels of 
the housekeeping ribosomal 18S and galectin-3 were PCR amplified in each sample by 
using specific primers (Advanced Nucleic Acids Core Facility, UTHSCSA, TX): 18S 
(sense) 5'-CATGTGGTGTTGAGGAAAGCA-3' and (anti sense) 5'-
GTCGTGGGTTCTGCATGATG-3'; Gal-3 (sense) 5'- 
CAGTGCAGAGGCGTCGGGAAA-3’ and (anti-sense) 5’-
CTGCCCCAGCAGGCTGGTTT-3’. The target gene expression levels were normalized 
to levels of the house keeping 18S gene in the same sample. Expression of galectin-3 in 
infected samples was determined as fold change over that in control samples as 
calculated by using the formula 2
−(ΔΔCt)
. 
Histological and Immunofluorescence staining 
For histological and immunofluorescence staining, frozen lung tissues were processed as 
previously described [77,82]. Frozen lung sections thus obtained were stained with 







) by immunofluorescence staining, as previously 
described [89] . For detection of cell death, TUNEL method was used according to 
manufacturer’s instructions (Chemicon International, CA). The images were acquired 
using a Leica DMR epifluorescent microscope (Leica Microsystems, Wetzlar, Germany) 
with an attached cooled CCD SPOT RT camera (Diagnostic Instruments Inc., Sterling 
Heights, MI). The images were processed and analyzed using Adobe Photoshop 7.0 
software (Adobe, Mountain view, CA).  
Enumeration of cellular infiltration in lungs 
Lungs were harvested from infected and mock control mice at 3 days p.i. after perfusion 
with PBS and were treated with collagenase to obtain single cell suspensions as 
previously described [77,78,90]. Total numbers of viable immune cells in lungs of 
infected and mock control galectin-3
-/-
 or WT mice were counted by trypan blue 
exclusion staining. 
Multi-analyte profile analysis 
The lung homogenates were prepared as described for the bacterial burden analysis above 
and were centrifuged at 2000 x g for 15 min to clear cellular debris. The supernatants 
were immediately frozen at -80
o 
C. The biomarker levels in lung homogenates were 
determined commercially by Myriad Rules-based Medicine (Austin, TX, USA) utilizing 
a multiplexed flow-based system: Mouse MAP
TM
 (Multi-Analyte Profiles) analysis 
technology. 
Neutrophil and macrophage activation  
Cells were isolated from the peritoneal cavities of naïve C57BL/6 mice 12-14h after 
intraperitoneal injection with sterile 4% thioglycollate. Neutrophil percentage was 
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determined by flow cytometry using neutrophil specific anti-mouse Gr-1 (anti-Ly-6G and 
Ly6C). Additionally, the lavage cells were cytocentrifuged on glass slides and were 
stained with H&E as described above.  The cells were plated at the density of 1x10
6
 cells 
and were infected with wild-type F.n. strain U112 at MOI 50 with or without 
pretreatment of the cells with 10µg/ml of purified recombinant galectin-3.  Cells 
stimulated with galectin-3 alone or with 10ng/ml of phorbol myristate acetate (PMA) 
served as controls. One hour after stimulation, production of reactive oxygen species 
(ROS) was measured in the cells by flow cytometry using Fc OxyBURST reagent 
according to the manufacturer’s instructions. A minimum of 10,000 events was read for 
each sample and all the cells fluorescing positive in FITC channel (excitation and 
emission maxima of ~490 nm and ~520 nm, respectively) were gated to get the 
percentage of ROS producing cells. 
 Bone marrow was isolated from wild-type and galectin-3
-/-
 mice and the cells were 
differentiated to macrophages as previously described [91]. On day 6 of culture 90-95% 
cells were macrophages as determined by flow cytometry using macrophage specific 
markers CD11b and F4/80.  The cells were plated at 8×10
4
 cells per well in 96-well flat-
bottom plates and were stimulated as described above for the neutrophils. Culture 
supernatants were collected 24h after stimulation and measurement of IL-6 and TNF-α 






Survival of the infected wild-type and galectin-3
-/-
 mice was compared using Kaplan 
Meier log Rank test. Statistical comparison between levels of host mediators in different 
experimental groups was performed by Student’s t test using Sigma Plot 8.0 
Results 
Galectin-3 is highly expressed and is localized extracellularly in lungs during the septic 
phase of F.n. infection.   
Alarmins are characterized as intracellular host factors which display extracellular release 
under pathological conditions. To examine if galectin-3 exhibits this alarmin property in 
pulmonary tularemia, the expression and distribution of this lectin was analyzed. We 
compared the transcript and protein level expression of galectin-3 at various times post-
infection (p.i.) in lungs of mice undergoing lethal pulmonary infection with the wild-type 
strain of F.n. versus the mice vaccinated with an attenuated mutant of F.n. (Mut/WT 
mice), which protects the mice from sepsis. This mutant has been characterized 
extensively in our previous studies [77]. As shown in Figure 1A, galectin-3 transcript 
levels showed maximal increase at 3 days p.i. (dp.i.) in the lungs of mice infected with 
the wild-type bacteria as well as in the Mut/WT mice. However, this increase was 
significantly higher in mice undergoing lethal infection as compared to the protected  
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Figure 1. Upregulated expression and extracellular release of Galectin-3 in lungs 
during respiratory F. novicida infection 
. (A) Total RNA was extracted by Trizol method from lungs harvested at the indicated 
times after infection with the Wild-type bacteria (WT) or from mice vaccinated with an 
attenuated mutant strain followed by challenge with WT bacteria (Mut/WT mice). The 
mRNA levels of Galectin-3 were analyzed by real-time PCR as described in Materials 
and Methods and are expressed as fold changes over the levels in mock control mice. Data 
shown are the averages of 3- 4 mice per group. Statistically significant differences are denoted by 
asterisks (**, p<0.005). (B) In-situ IF staining of frozen lung sections from mock infected and 
WT U112 infected or Mut/WT mice harvested at 3 d. p.i  Lung harvested 3 weeks after 
vaccination with the mutant alone (Mut-3wk) served as controls for Mut/WT mice. The sections 
were stained for galectin-3 (red) using a purified rat anti-mouse galectin-3 antibody followed by 
Alexa-546 conjugated chicken anti-rat antibody. Nuclei (blue) were stained with 4’6’ diamidino-
2-phenylindol-dilactate (DAPI). Magnification X 200. Insets depict extracellular galectin-3 in 








Mut/WT mice. This increase in galectin-3 expression at 3 dp.i. is consistent with the 
appearance of other sepsis features (extensive cell death, hyperinflammatory response, 
increased vascular injury) at this time, as shown in our previous studies with F.n. as well 
as the fully virulent F. tularensis [77,78]. We thus termed this as septic phase of 
Francisella infection and carried out the rest of our analysis at this time point. 
Immunofluorescence (IF) analysis of galectin-3 protein expression in frozen sections of 
lungs harvested at 3dp.i. showed a low basal level expression in mock infected mice 
inoculated with PBS alone (Fig. 1.B1). Consistent with the transcript data, lungs of mice 
undergoing septic infection with the wild-type F.n. exhibited upregulated expression of 
this lectin at 3d p.i. (Fig. 1. B2). This increase in expression was substantially higher than 
that in Mut/WT mice (Fig.1.B4). The mice infected with mutant alone for 3 weeks and 
without challenge with WT bacteria (Mut-3wk) served as control for the Mut/WT mice. 
In these mice, galectin-3 was observed to be expressed at low basal level similar to mock 
control animals (Fig. 1B3). Importantly, most of galectin-3 expressed in septic mice was 
localized extracellularly in large granuloma-like areas of cellular infiltration, undergoing 
extensive cell death (Fig. 1.B2’). The non-septic Mut/WT mice, on the other hand, 
showed intracellular galectin-3 associated with live cells (Fig. 1.B4’). Western blot 
analysis of bronchoalveolar lavage (BAL) from mice infected with the WT F. novicida 
also showed a significantly high extracellular release of galectin-3 (Fig. 2). Taken 
together, these data clearly showed that galectin-3 exhibits a characteristic alarmin 





Figure 2. Upregulated expression and extracellular release of Galectin-3 in lungs 
during respiratory F. novicida infection.  
Bronchoalveolar lavage (BAL) was obtained from lungs of mice infected with the wild-
type F. novicida strain U112 or PBS alone as previously described (9).  Galectin-3 was 
immunoprecipitated from BAL using a purified rat anti-mouse galectin-3 antibody 
(eBioscience, San Diego, CA) by previously described method [92] with modifications. 
Briefly 1 mg of total BAL proteins were incubated with 10 µg anti-galectin-3 antibody at 
4
o
C overnight. Immune complexes were pulled down with using 30 μl of 30% Protein A 
Plus agarose beads (Pierce) for 2h at 4
o
C. The beads were washed, solubilized in 1× SDS 
gel loading buffer and resolved on 12% acrylamide gels (BioRad). The gels were  
processed for western blotting as described previously [77] for detection of galectin-3 
using anti-mouse galectin-3 antibody. Densitometric analysis of bands was performed 
using the Lumi-Imager software (Roche Applied Science). Bar graph depicts 
densitometry analysis of galectin-3 bands represented in arbitrary units. Statistically 





 mice display reduced inflammatory response and 
neutrophil accumulation 
We hypothesized that, similar to the function of alarmins, increased expression and 
extracellular localization of galectin-3 may be contributing to the hyperinflammatory 
response culminating in sepsis during lethal Francisella infection.  In order to analyze 
this, lungs were harvested at 3d.p.i. from F.n. infected galectin-3
-/-
 and wild-type mice 
and the levels of multiple cytokines, chemokines as well as vascular injury markers were 
measured using a multiplex assay. Galectin 3
-/-
 mice displayed significant reduction in 
levels of several vascular injury markers in comparison with their wild-type counterparts 
(Fig. 3A). In addition, levels of several inflammatory cytokines (TNF-α, IL-10, IL-1β), 
described as markers of sepsis, were reduced in galectin-3
-/-
 mice (Fig. 3B). These 
observations strongly suggested an immune-stimulatory role of galectin-3 during 
pulmonary Francisella infection. Interestingly, in comparison with wild-type mice, 
infected galectin-3
-/-
 mice displayed a reduction in several chemokines involved in 
neutrophil recruitment (Fig. 3C). Furthermore, levels of myeloperoxidase (MPO), a 
neutrophil associated protease and marker of neutrophil activation, was also reduced in 
infected galectin-3
-/-
 mice. In order to correlate these observations with cellular 
infiltration in-vivo, IF staining for co-expression of CD11b and Gr1, markers for 
activated neutrophils [93], was performed on lung sections from galectin-3
-/-
 and wild-
type mice. Consistent with the chemokine data, cells infiltrating the lungs of infected 
wild-type mice showed high co-expression of CD11b and Gr1, suggesting an activated 
neutrophil phenotype. These cells were mostly accumulated in large lesion like areas in 
the lungs of these mice. The cells in infected galectin-3
-/-





 mice display reduced levels of inflammatory mediators in 
lungs after pulmonary infection with F.n.  
The lungs from WT mock infected (WT-M), galectin-3
-/-
 mock infected (Gal-3
-/-
M), WT 
F. novicida infected (WT-Inf) or galectin-3
-/-
 F. novicida infected mice (Gal3
-/-
Inf) were 
harvested at 3 d.p.i., homogenized with protease inhibitors in PBS and analyzed 
commercially for rodent multi-analyte profiles (Rules-Based Medicine, Austin, TX). (A), 
levels of vascular injury markers; (B), levels of inflammatory cytokines; and (C), levels 
of neutrophil attractant chemokines and activation markers in lung homogenates. Results 
shown are from 3-4 mice per group from 3 different experiments. CRP; C-reactive 









 mice display reduced accumulation of neutrophils in lungs 
during F.n. infection.  
Frozen sections of lungs harvested at 3 d. p.i.  from mock infected and F. novicida 
infected WT or galectin-3
-/-
 mice were co-stained with antibodies against myeloid cell 
markers CD11b (red) and Gr1 (green). A high co-expression of both markers is depicted 
by yellow color in infected WT lungs while cells infiltrating lungs of galectin-3
-/- 
mice 
exhibited expression of only CD11b. Nuclei (blue) were stained with 4’6’ diamidino-2-
phenylindol-dilactate (DAPI). Magnification X 200.  Asterisks depict lesions in the lungs.  
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expressed CD11b, but low or no Gr1 (Fig. 4). These results suggested a role of galectin-3 
in regulation of myeloid cell accumulation, particularly neutrophils, in the lungs of mice 
during pulmonary F.n. infection.  
Galectin-3 regulates F.n. infection induced inflammatory response in-vitro  
In order to further investigate the immune stimulatory properties of galectin-3, we 
examined the role of this lectin in in-vitro activation of myeloid cells, particularly 
neutrophils and macrophages. These are the major cell types that infiltrate the lungs of 
Francisella infected mice [77,94]. In-vitro infection of WT bone marrow derived 
macrophages (BMDMs) with wild-type F.n. U112 resulted in an inflammatory response 
in terms of increased TNF-α and IL-6 production (Fig. 5A). Galectin-3
-/-
 macrophages on 
the other hand, produced significantly lower amounts of these cytokines in response to 
infection (Fig. 5A). As the extracellularly released galectin-3 may be playing a role in 
activation of myeloid cells in-vivo, we examined if pretreatment of these cells with 
galectin-3 has any effect on Francisella infection induced cytokine production. 
Stimulation of macrophages with purified galectin-3 induced minimal amount of TNF-α  
and IL-6 production (Fig. 5B). The optimal concentration of galectin-3 was 
experimentally determined by using 1-20µg/ml of the recombinant protein (data not 
shown). Infection with wild-type F.n. strain U112 infection, on the other hand, induced 
substantial amounts of these cytokines in macrophages. Interestingly, pre-treatment of 
macrophages with purified galectin-3 exacerbated this Francisella-induced inflammatory 
cytokine production (Fig. 5B). Immune stimulatory effect of galectin-3 was also 
examined on peritoneal neutrophils. Cells collected by peritoneal lavage following  
32 
 
Figure 5.  Galectin-3 regulates F.n. infection induced inflammatory response in-vitro.  
(A). Bone marrow derived macrophages (BMDMs) were isolated from wild-type and 
galectin-3
-/-
 mice as described in Methods. The cells were infected with wild-type F.n. 
Strain U112 at MOI of 50 and the culture supernatents were collected 24h after infection. 
The amount of TNF-α and IL-6 were measured in the supernatents by Sandwich ELISA. 
(B). BMDMs from C57Bl/6 wild-type mice were infected with wild-type F.n. Strain 
U112 at an MOI of 50 with or without pretreatment with 10µg/ml of purified 
recombinant galectin-3. Culture supernatants were collected 24h after infection and the 
amount of TNF-α and IL-6 were measured by ELISA. The experiment was repeated three 
times with similar results. (C). Peritoneal neutrophils were isolated from mice 12-14h 
after injection with 4% thioglycollate and were stimulated with F. novicida at an MOI 50 
with or without pre-treatment with purified recombinant galectin-3 (10µg/ml). 
Stimulation with galectin-3 alone or phorbol myristate acetate (PMA, 10ng/ml) was used 
as a control. Production of reactive oxygen species was measured one hour post-
stimulation by flow-cytometry using Fc-OxyBURST dye following the manufacturer’s 
instructions. Numbers in black on the plots depict percent of ROS positive cells and the 
numbers in green represent median fluorescence intensity (MFI) of individual cells. Dot 
plots from a representative of 3 independent experiments are shown.  
Statistical analysis between the data sets was performed by Student’s t test where **p < 







Figure 6. Flow cytometry analysis of peritoneal neutrophils.  
Mice were injected intraperitoneally with sterile 4% thioglycollate. Peritoneum was 
lavaged 12-14hrs later and cells were analyzed by flow cytometry using neutrophil 
specific anti-mouse Gr1 (Ly6G+Ly6C)  antibody. In addition, cells were cytocentrifuged 
and stained with H&E for morphological analysis.  
35 
 
intraperitoneal injection of thioglycollate were 80-85% neutrophils as determined by flow 
cytometry and morphological analysis with characteristic multilobed nuclei (Fig. 6). 
Unlike macrophages, treatment of neutrophils with purified galectin-3 alone activated 
these cells to produce substantial levels of ROS as determined by oxidation of Fc 
OxyBURST dye (Fig. 5C). Importantly, pre-treatment of neutrophils with this lectin 
primed these cells to produce further increased amounts of ROS in response to F.n. 
infection, which was significantly higher than that elicited by F.n. infection alone (Fig. 
5C). This cell-type specific response of galectin-3 indicates involvement of distinct 
receptors and/or signaling pathways, which is currently being investigated in our 
laboratory. Nonetheless, this augmentation of Francisella infection-induced myeloid cell 
activation by galectin-3 likely has implications in exacerbation of inflammation 
culminating in sepsis development during this infection.   
Galectin-3
-/-
 mice exhibit reduced lung pathology after F.n. infection.  
Lung cryosections from wild-type and galectin-3
-/-
 mice infected with a lethal dose of 
F.n. were stained with H&E and processed for histopathological analyses as described in 
Materials and Methods. Mock infected wild-type and galectin-3
-/- 
mice exhibited similar 
normal lung architecture with minimal cellular infiltration and clear air spaces (Fig. 7A). 
As expected, a massive increase in cellular infiltration and extensive pathology, along 
with severe bronchopneumonia and massive cell death occurring in the center of large 
granuloma-like areas of infiltration, was evident in the lungs of wild-type mice at 3 dp.i. 
(Fig 7A).  The lungs of galectin-3
-/-
 mice, on the other hand, showed moderate 
peribronchial and perivascular infiltration (Fig. 7A). The infiltrating cells in these areas 
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Figure 7. Galectin-3 deficiency leads to improved lung pathology, reduced leukocyte 
accumulation and reduced cell death upon pulmonary F.n. infection.  
(A) Lungs from mock infected and F.n. infected wild-type (WT) or galectin-3
-/-
 mice 
were harvested at the septic phase (3 d. p.i.), embedded in optimal-cutting-temperature 
(OCT) compound, and sectioned as described in Materials and Methods. The frozen 
sections were stained with Hematoxylin and Eosin. The images obtained are 
representatives of three experiments performed, and in each experiment each group 
contained three mice. Magnification, ×200.  (B). Lungs from mock infected and F.n. 
infected WT or galectin-3
-/-
 mice were harvested 3 days after intranasal infection.  Total 
immune cells infiltrating the lungs were isolated by collagenase treatment of lungs as 
described in Materials and Methods. Total numbers of viable immune cells were counted 
by trypan blue exclusion staining (n = 5-6). Statistical analysis between the data sets was 
performed by Student’s t test where **p < 0.005. (C). Frozen lung sections from mock 
infected and Francisella infected WT or galectin-3
-/-
 mice were processed for in-situ 
TUNEL staining for detection of DNA fragmentation (red) in nuclei. Nuclei (blue) were 






appeared to be viable and the areas of infiltration lacked cellular debris that is typical of 
extensive apoptosis and necrosis in the wild-type mice. This was consistent with reduced 
numbers of leukocytes enumerated after collagenase treatment of the lungs harvested 
from galectin-3
-/-
 mice (Fig. 7B). Galectin-3 deficiency did not affect the basal number of 
cells as mock infected wild-type and galectin-3
-/-
 animals showed similar low number of 
cells in the lungs. To further analyze the extent of cell death in the lungs of infected wild-
type and galectin-3
-/-
 mice, TUNEL assay was performed on frozen sections of lungs 
harvested at 3 dp.i. As shown in Fig. 7C, mock infected wild-type and galectin-3
-/-
 mice 
showed minimal numbers of TUNEL positive cells in their lungs. On the other hand, 
septic lungs of F.n. infected wild-type mice showed extensive cell death within 
perivascular and peribronchial lesions which are the main sites of immune cell infiltration 
during infection (Fig. 7C). In contrast, the numbers of apoptotic TUNEL positive cells in 
infected galectin-3
-/-
 mice were much less as compared to their wild-type counterparts 
following infection with F.n. The improved lung architecture and reduced cell death in 
the absence of galectin-3 indicates a pathological role of this lectin during pulmonary 
Francisella infection.  
Galectin-3
-/-
 mice show improved survival following F.n. infection. 
In order to see the effect of improved lung pathology and reduced inflammatory 
responses in the absence of galectin-3, overall disease severity and survival was 
compared in C57BL/6 wild-type and galectin-3
-/-
 mice infected with a lethal dose of F.n. 
In the infected wild-type mice, visible signs of disease started to appear by day 3 p.i. 
which typically included piloerection, hunched gait, lethargy, and eye discharge. All of 








 mice show improved survival during pulmonary F.n. 
infection.  
(A). Fifteen C57Bl/6 WT and 17 galectin-3
-/-
 mice in 3 separate experiments were 
inoculated intranasally with F. novicida and were monitored for survival daily for 2 
weeks. The improved survival of galectin-3
-/-
 mice compared to WT mice was 
statistically significant, as determined by Kaplan-Meier log-rank analysis (P value*** = 
0.0003). (B) Bacterial burdens in lungs harvested from F. novicida infected WT and 
galectin-3
-/-
 mice at 3 d.p.i. Lungs and liver were harvested from infected mice, 
homogenized as described in Materials and Methods. Tissue homogenates and blood 
harvested at the same time, were serially diluted and plated on TSA plates to enumerate 
bacterial burdens. In this representative of three independent experiments, each group 
contained three to five mice.  
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exhibited delayed appearance of disease symptoms and showed significantly improved 
survival as compared to the infected wild-type mice (Fig. 8A). Intriguingly, enumeration 
of bacterial burden in the organs of these mice at the peak of infection, i.e., 3 d.p.i. 
showed that both galectin-3
-/-
 and the wild-type animals exhibited similar bacterial 
burdens in their systemic organs as well as in blood (Fig. 8B).  
Discussion 
 Sepsis is the 2
nd
 leading cause of death in ICU patients and pulmonary infections in turn 
are a major source of sepsis [5]. It is a complex immune disorder resulting from 
deregulation of multiple host defense pathways. Accumulating evidence suggests that 
host endogenous molecules termed alarmins, likely play an important role in 
pathophysisology of sepsis [95]. In this study we show that galectin-3, a mammalian β-
galactoside binding lectin acts as a novel alarmin in development of sepsis during 
pulmonary infection with F. novicida. Consistent with characteristic properties of 
alarmins, galectin-3 was upregulated and extracellularly released during the septic phase 
of infection and could amplify the Francisella infection-induced inflammatory response 
of neutrophils and macrophages. Furthermore, galectin-3
-/-
 mice showed improved 
pathology, reduced inflammation and improved survival during pulmonary Francisella 
infection. These results suggest that galectin-3 functions as an alarmin and plays a 
pathogenic role in development of sepsis in pulmonary bacterial infection.   
Alarmins are structurally diverse multifunctional host proteins with some common 
properties (12-15). These are endogenous proteins performing homeostatic functions that 
lack any signal sequence for active secretion and have chemoattractant and immune 
activating properties, once released in extracellular milieu. With advances in our 
41 
 
understanding of host responses to pathogenic events, the list of alarmins has continued 
to grow over the past decade. Several well characterized alarmins such as High Mobility 
Group Box1 (HMGB-1), S100 family of proteins, and heat shock proteins have been 
shown to perform dual functions as factors controlling homeostatic processes like 
transcriptional regulation when localized to intracellular compartments and as pro-
inflammatory factors upon their release from necrotic cells during a pathogenic insult 
[32,33,96]. Similarly, galectin-3 when localized in the nucleus, has been shown to act as 
an RNA splicing factor [97] and performs homeostatic functions such as embryogenesis 
and cell cycle regulation [63]. The results of current study showed that galectin-3 can be 
released extracellularly in lungs under pathogenic conditions such as an infection. 
Curiously, galectin-3 does not contain any signal sequence for golgi mediated classical 
secretion. Thus active secretion of this lectin is likely via a yet unclear non-classical 
secretion pathway, a property shared by most alarmins characterized to date [66]. 
However, in F.n. infection, this lectin is likely released passively from dead/dying cells 
since the extracellular galectin-3 is detected only during lethal infection with F.n., which 
typically results in extensive cell death [77,78,80]. On the other hand, the mice 
vaccinated with an attenuated F.n. mutant causing little or no cell death showed this lectin 
to be intracellular and largely associated with live cells, with minimal levels in BAL. 
Notwithstanding the mechanism involved, release of galectin-3 in the septic phase of F.n. 
infection indicates a role for this molecule in pathogenesis of this infection.    
Consistent with alarmin properties, galectin-3 exhibited immune activating properties 
such as stimulation of oxidative burst in neutrophils and inflammatory cytokine 
production in macrophages. Importantly, this lectin was able to augment F.n. infection 
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induced inflammatory response from neutrophils as well as macrophages, which can have 
important implications under in-vivo conditions. Previous studies from our laboratory 
have shown that pulmonary infection with F.n., as well as F. tularensis, results in 
extensive cell death and that F.n. infected phagocytes are defective in efferocytosis, the 
process of clearing dead cell debris [74]. Coinciding with this, we have further shown 
that pulmonary Francisella infection is characterized by hyperinflammatory response 
with an unbridled increase in levels of several inflammatory cytokines as well as vascular 
injury markers [77,80]. It is likely that during pulmonary Francisella infection, galectin-3 
released from these dead cells primes the bystander myeloid cells to produce heightened 
levels of inflammatory mediators in response to the bacteria, resulting in further tissue 
damage and ultimately organ failure, characteristic of sepsis. Curiously, while the 
macrophages did not respond to galectin-3 alone, neutrophils displayed ROS production 
upon stimulation with galectin-3 or F.n. infection alone, which was amplified upon 
combination of the two.  This cell-specific nature of galectin-3 activity in the context of 
Francisella infection is interesting and is in line with a previous study showing the role of 
prototype alarmin HMGB1 in promoting the inflammatory response of monocytes 
elicited by external stimuli [98]. Intriguingly, in that study as well, the monocytes did not 
respond to HMGB1 alone. In light of several biologically  
distinct functions performed by alarmins ranging from inflammation to tissue repair and 
wound healing, association with other stimuli possibly adds another layer to the 
regulation of their mechanisms of action. Although speculative at this stage, it is possible 
that the activating receptor for galectin-3 on neutrophils is constitutively expressed while 
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that on macrophages likely gets expressed in an infection-specific manner. Further 
studies to test this hypothesis are currently underway in our laboratory.  
As mentioned earlier, one of the characteristic properties of alarmins is to mediate 
immune cell influx. The reduced number of leukocytes in infected galectin-3
-/-
 animals in 
this study indicates that this lectin likely plays a role in recruitment of these cells in 
sepsis.  Reduced levels of neutrophil chemoattractants and activation markers in galectin-
3
-/-
 mice support this notion. This observation is in line with the role of prototypic 
alarmin HMGB1 in neutrophil migration by regulating the levels of chemoattractants 
such as IL-8 [99].  Additionally galectin-3 may also play a direct role in extravasation of 
neutrophils from blood vessels into the lungs, as shown in a previous study with 
pulmonary S. pneumonia infection [65]. Other proinflammatory alarmins such as S100 
proteins have also been shown to directly promote migration of myeloid cells by binding 
to their cell surface receptors [100,101]. Another possibility is that galectin-3 may have a 
role in inhibiting neutrophil turnover. Under the conditions of a resolving inflammatory 
response to an infectious insult, once the neutrophils have performed their antimicrobial 
function, they undergo programmed cell death. The failure of this process is the root 
cause of several inflammatory disorders, as prolonged exposure to neutrophilic factors 
can result in non-specific tissue damage [102]. In this regard a recent study showed a 
defect in neutrophil turnover and thus the lack of resolution of inflammation during 
Francisella infection [103]. Furthermore, a previous study has shown the involvement of 
galectin-3 in decreasing neutrophil death as well as reducing macrophage cell death in 
response to apoptotic stimuli [104,105]. This suggests that expression of galectin-3 in 
inflammatory cells may lead to their enhanced survival, resulting in exacerbated 
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inflammation. Thus it is tempting to speculate that galectin-3, in addition to activating 
neutrophils, may be playing a role in inhibition of neutrophil turnover during Francisella 
infection by prolonging the lifespan of these cells. Consistent with this hypothesis, F.n. 
infected galectin-3
-/-
 mice show reduced numbers of neutrophils, lower levels of 
neutrophil associated immune mediators and consequently reduced tissue pathology. 
These observations further support proinflammatory and pathogenic role of galectin-3 in 
pulmonary F.n. induced sepsis.        
Extensive tissue pathology is a major complication of acute respiratory infections which 
are associated with severe sepsis [106,107].  This is caused by hyper activation of the 
inflammatory immune response that results in capillary leakage, tissue injury, and 
ultimately lethal organ failure [108,109]. Results from the current study showed that F.n. 
infected galectin-3
-/-
 animals exhibited a reduction in the levels of sepsis mediators such 
as vascular injury markers thrombopoietin, fibrinogen, as well as acute phase protein 
CRP and inflammatory cytokines such as TNF-α, IL-6 and IL-1. This observation further 
suggested that galectin-3 mediates upregulation of these sepsis markers during 
Francisella infection and thus plays a role in development of sepsis. As a result of this 
mitigated inflammatory response and tissue pathology, galectin-3
-/-
 mice are able to 
survive the infection for a significantly longer duration as compared to infected wild-type 
mice. Galectin-3
-/-
 mice have been shown to be highly resistant to infection with another 
Gram negative bacterium Salmonella [86] with KO mice exhibiting lower bacterial 
burdens. Although the mechanism of this protection was not shown, it was speculated 
that galectin-3 binds to and masks bacterial PAMPs resulting in immune suppression and 
unchecked bacterial growth. Previous studies have shown the ability of galectin-3 to bind 
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to a variety of pathogens [110-113] owing to its specificity for β-galactosides which are a 
common constituent on pathogen membranes. This interaction can serve to activate 
immune response as well as result in direct killing of the pathogen as shown in case of 
Candida [112]. Since we observed similar bacterial burdens in F. novicida infected 
galectin-3
-/-
 and wild-type mice, it seems unlikely that galectin-3 is involved in direct 
killing of bacteria. It is, however, possible that galectin-3 could be binding to a 
Francisella factor thus potentiating its interaction with immune activating receptor/s, as 
has been shown in case of HMGB1 [98]. Studies regarding the identity of Francisella 
factors possibly engaged by galectin-3 and immunological consequences of these 
interactions are currently on-going in our laboratory.  The survival advantage of F. 
novicida infected galectin-3
-/-
  was observed to be only transient as these mice ultimately 
succumbed to infection, possibly due to overwhelming bacterial burdens. Interestingly, 
this survival advantage of galectin-3
-/-
 mice was dependent on the infection dose of 
bacteria. The galectin-3
-/-
 mice succumbed to the infection at a similar rate as WT mice 
when infected with 300-500 CFUs of bacteria (data not shown). It is possible that at that 
dose, a higher bacterial burden leads to a further increase in cell death leading to an 
increased accumulation of other alarmins which mask the advantageous effect of the 
absence of galectin-3. This observation highlights the complex nature of sepsis syndrome 
where multiple host and pathogen derived factors cross talk and regulate various immune 
pathways. It is also consistent with previous studies showing partial or no protection upon 
blocking single alarmin such as HMGB1 [114-116]. Nonetheless, as the bacteria can be 
cleared by successful antibiotic therapy, the complications often arise from tissue damage 
during sepsis. Thus, a combinatorial approach using blockage of galectin-3 along with 
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antibiotics could prove to be a successful therapy for treating Francisella infection 
induced sepsis. 
In Toto, our findings indicate that galectin-3 plays a pathogenic role as an alarmin to 
exacerbate the inflammatory response during pulmonary infection with Francisella and 
contributes to sepsis development. Galectin-3 thus may represent a potential target for 
treatment of sepsis during this infection.   
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Summary sentence: In this brief conclusive report the authors present data to implicate an 
orphan C-type lectin receptor in resolution of inflammation by facilitating neutrophil 
turnover    




Pneumonia is frequently associated with sepsis characterized by a non-resolving 
hyperinflammation. However, specific host components of the pulmonary milieu that 
regulate the perpetuation of inflammation and tissue destruction observed in this immune 
disorder are not clearly understood. We examined the function of Clec4d, an orphan 
mammalian C-type lectin receptor, in Gram pneumonic sepsis caused by Klebsiella 
pneumoniae.  While the wild-type mice infected with a sublethal dose of bacteria could 
resolve the infection, the Clec4d
-/-
 mice were highly susceptible with a progressive 
increase in bacterial burden, hyperinflammatory response typical of sepsis and severe 
lung pathology. This correlated with a massive accumulation of neutrophils in lungs of 
infected Clec4d
-/-
 mice which was in contrast with their wild-type counterparts where 
neutrophils transiently infiltrated the lungs.  Interestingly, the Clec4d
-/-
 neutrophils did 
not exhibit any defect in bacterial clearance. These results suggest that Clec4d plays an 
important role in resolution of inflammation, possibly by facilitating neutrophil turnover 
in lungs. This is the first report depicting physiological function of Clec4d in a 
pathological condition. The results can have implications not only in sepsis but also other 





Sepsis poses a major health care burden with 750,000 cases annually in the United States 
with a mortality rate of 20-50% [5]. Currently there are no effective therapies to treat this 
deadly immune disorder. Pneumonia is the most frequent source of sepsis [117]. In that 
regard, nosocomial infections caused by the opportunistic pathogen Klebsiella 
pneumoniae (KPn) account for 5-20% of Gram-negative sepsis cases. In light of constant 
occurrence of antibiotic resistant strains of this pathogen, an understanding of functioning 
of host innate immune components might provide targets for modulation of host immune 
system in a beneficial manner [118,119].  
Sepsis is now perceived as interplay of pathogen derived (pathogen associated molecular 
patterns, PAMPs) as well as endogenous host factors (termed alarmins [120]. C-type 
lectin receptors (CLRs) are emerging as pattern recognition receptors which can shape 
immune responses by recognizing a variety of PAMPs as well as alarmins [121]. 
However, their function in development of sepsis is largely unexplored. In that regard, 
Clec4e (Mincle) of Dectin-2 subfamily has recently been shown to function as an 
activating receptor for host endogenous factors released from dead cells and PAMPs of 
bacterial and fungal origin [49].  Clec4d, another Dectin-2 family member is localized 
close to Mincle in NK gene complex region of chromosome 12p13 and its function is yet 
to be defined [122,123]. Based on the close vicinity of this receptor with Mincle, we 





In this study we tested the role of Clec4d in Gram negative sepsis induced by pulmonary 
infection with KPn. Our results show that Clec4d-mediated responses are required for the 
resolution of pneumonia and to mitigate mortality in pulmonary KPn induced sepsis. This 
may have implications for other immune disorders associated with non-resolving, 
persistent inflammation. 
Materials and Methods 
Infection of mice and survival  
Six to 8 weeks old female wild-type C57BL/6 and Clec4d
-/-
 mice (obtained from the 
Consortium of Functional Genomics) bred in the animal facility of the University of 
North Dakota were used according to institutional and federal guidelines. Mice were 
infected intranasally with sublethal dose (5 x 10
4
 bacteria in 20ul of saline, determined 
experimentally) of KPn (ATCC strain 43826). The bacteria were grown to log phase in 
LB medium. Mock infected mice received saline only. Mice were monitored daily for 
signs of disease, which typically included piloerection, hunched gait, lethargy, weight 
loss and increased respiratory rate. The survival of infected mice was recorded for up to 2 
weeks post-infection (p.i.).  
Bacterial Burden and Multi-analyte profile analysis 
Lungs and livers from infected and mock mice at various times post-infection (p.i.) were 
immediately removed after perfusion were homogenized aseptically in cold PBS with 
Complete
TM
 protease inhibitor cocktail (Roche Diagnostics, Germany), all described by 
us previously [77,124].  For the bacterial burden analyses, the organ homogenates and 
blood were serially diluted in PBS and plated on LB agar. The immune mediators in lung 
homogenates were determined commercially by Myriad Rules-based Medicine (Austin, 
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TX, USA) utilizing a multiplexed flow-based system: Rodent MAP
TM
 (Multi-Analyte 
Profiles) analysis technology. 
qRT-PCR 
Lungs from infected and mock mice at various times post-infection (p.i.) were 
immediately removed after perfusion and were used to extract total RNA by Trizol 
reagent (Invitrogen) according to the manufacturer’s instructions. Real-time PCR analysis 
of the samples was performed, as described previously [124] using SYBR green (Applied 
Biosystems, CA, USA) to measure the expression levels of Clec4d-specific mRNAs by 
using specific primers Clec4d (sense) 5'- GAA CAA ATT CTT GCC GTC CTG ACC-3’ 
and (anti-sense) 5’-TCC ATC ACA AGG ACC ACT TTC TGA G-3’ (Integrated DNA 
Technologies, Inc., Iowa). The target gene expression levels were normalized to levels of 
the house keeping 18S gene (sense) 5'-CATGTGGTGTTGAGGAAAGCA-3' and (anti 
sense) 5'-GTCGTGGGTTCTGCATGATG-3' in the same sample. Expression of Clec4d 
in infected samples was determined as fold change over that in control samples as 




Lungs from infected and mock mice at various times post-infection (p.i.) were isolated 
after perfusion were snap-frozen in OCT resin. For pathological analysis 10 µm thick 
serial horizontal sections of frozen lungs were stained with hematoxylin and eosin (H&E) 
as described previously [77].   
Flow Cytometry 
For enumeration of neutrophils by flow cytometry, lungs from mock control and infected 
animals isolated 3 days p.i. (dp.i.) were processed to get total cellular infiltrates as 
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previously described by us [77]. Ly6G+CD11b+ neutrophils were quantified using 
Pacific BlueTM anti-mouse CD11b and APC anti-mouse Ly6G antibodies (Biolegend, 
San Diego, CA).  
Bacterial phagocytosis and killing activity of neutrophils 
For assessing KPn phagocytosis, peritoneal neutrophils were isolated by previously 
described method [125] and were incubated with GFP-labeled KPn (kindly provided by 
Dr. Steven Clegg, University of Iowa) at MOI of 50 with or without opsonization in 10% 
normal mouse serum. After 1 hour, the cells were washed twice with ice-cold PBS 
followed by two washes with FACS-buffer (PBS+10% fetal bovine serum). The % 
positive cells containing fluorescent bacteria were determined by flow-cytometry using 
BD LSR II (Becton Dickinson Immunocytometry, San Jose, CA.). For bacterial killing 
activity, intracellular CFUs in Clec4d
-/-
 and WT neutrophils were enumerated at 1h and 
3hp.i. by gentamycin protection assay as described previously [126].  
Statistics 
Statistical analysis of survival studies was performed by Kaplan Meir log-rank test; 
bacterial burdens by non-parametric Mann-Whitney Test. All other statistical analyses 





RESULTS AND DISCUSSION 
In order to investigate the role of Clec4d in KPn pneumonia, we first examined if the 
Clec4d
-/-
 and WT mice respond to pulmonary KPn infection differentially. For this we 
initially infected the mice intranasally with a lethal dose of 1x10
5
 CFUs (determined 
experimentally). One hundred percent of the WT mice died within 5 dp.i. at this dose 
while all the Clec4d
-/-
 mice reproducibly succumbed to infection 1-2 days earlier than the 
WT mice (data not shown). In order to finalize a dose at which the WT mice would 
display minimal morbidity and mortality while the Clec4d
-/-
 mice would all succumb to 
infection, mice were infected with sublethal dose of 5x10
4
 CFUs. As shown in Fig. 9A, 
70-80% of WT mice infected with 5x10
4
 CFUs of KPn survived the infection with 
transient signs of disease (ruffled fur, lethargy) early during infection and appeared 
healthy later. The Clec4d
-/-
 mice, in contrast, were extremely susceptible to this dose. 
Majority of these mice died within 5dp.i. and 100% of mice succumbed to infection by 
day 7 with progressive development of disease and overt signs of infection (piloerection, 
hunched gait, lethargy, increased respiratory rate). Importantly while the disease signs 
appeared at similar times (2dp.i.) in WT and Clec4d
-/-
 mice, they became divergent by 
3dp.i. While the WT mice appeared to enter recovery phase at that time, the Clec4d
-/-
 
mice continued to display disease progression. The recovery phase of WT mice strongly  
correlated with the expression level of Clec4d in their lungs where Clec4d mRNA was 
maximally transcribed by 3dp.i. (Fig. 9B). This was followed by a downregulation in 
Clec4d transcript that was reduced to only marginal levels by 5dp.i. These results 
indicated a protective role of this receptor in the resolution of KPn pneumonia.  
54 
 
Next, serial dilutions of homogenized lungs, liver and blood from infected Clec4d
-/-
 and 
WT mice were plated on LB. For initial 2 days, the Clec4d
-/-
 and WT animals displayed 
similar bacterial burdens in their lungs (Fig. 9C). Overwhelming loads were detected in 
lungs of Clec4d
-/-
 mice at 3dp.i. which remained high at 5dp.i., the time when majority of 
mice had become moribund. In contrast, the WT mice displayed 3-5 logs lower bacterial 
burden at 3dp.i. and the counts continued to drop through 5dp.i., indicating a resolution 
of the infection in these mice. The Clec4d
-/-
  mice also displayed higher and earlier 
systemic dissemination of bacteria as depicted by significantly higher bacterial load in 
liver even at 2dp.i. and a more severe bacteremia (Fig. 9C). In contrast, no viable bacteria 
were detected in the blood of WT mice by 5dp.i. These data indicated that Clec4d 
mediated responses directly or indirectly influenced bacterial clearance in pneumonic 
infection with KPn.  
To examine if the inability of Clec4d
-/-
 mice to clear bacteria was due to a defect in 
mounting inflammatory response, pro-inflammatory cytokines in infected mice lungs 
were analyzed.  In both strains, mock infected mouse lungs displayed similar low basal 
levels of inflammatory cytokines tested (TNF-α, IFN-γ, IL-6, IL-17) (Fig. 10A). Upon 





 mice display increased mortality accompanied with 
overwhelming bacterial burden in systemic organs during Gram negative 
pneumonia.  
(A). Sixteen WT (C57BL/6) and seventeen Clec4d
-/-
 mice were intranasally infected with 
5X10
4
 CFUs of Klebsiella pneumonia (KPn) in 20µl of sterile PBS and were assessed 
daily for disease severity. The increased susceptibility of Clec4d
-/-
 mice as compared to 
WT mice is statistically significant as determined by Kaplan-Meier survival curve 
statistical analysis (p<0.001). (B) Total RNA was extracted by Trizol method from lungs 
harvested at the indicated times after infection with 5X10
4
 CFUs of KPn. The mRNA 
levels of Clec4d were analyzed by real-time PCR as described in Materials and Methods 
and are expressed as fold changes over the levels in mock control mice calculated by 
using the formula 2
−(ΔΔCt)
. Data shown are the averages of 6-8 mice per group in two 
independent experiments. (C). WT and Clec4d
-/-
 were intranasally infected with 5X10
4
 
CFUs of KPn. At indicated times post infection the mice were sacrificed, systemic organs 
were isolated, homogenized and plated as described in Materials and Methods. Bacterial 
burden was enumerated after incubating the plates overnight at 37
o
C.  The data shown is 
from one representative experiment (5 animals at each time point) out of three performed with 
similar results. Significant differences in bacterial burden (using non-parametric Mann-
Whitney test) in WT and Clec4d
-/- 







started to drop by 3dp.i. and were reduced to minimumby 5dp.i. (Fig. 10A). This was 
consistent with the reduced bacterial burden in these mice at these times post-infection.  
In contrast, infection of Clec4d
-/-
 mice resulted in a progressive increase in levels of these 
cytokines through the course of infection, showing a massive upregulation at 3d and 
5dp.i. Interestingly, at 1dp.i., the levels of these cytokines were slightly lower than those 
in the WT mice at that time p.i., however the differences were not statistically significant. 
Of note, unlike the pro-inflammatory cytokines tested, the amount of IL-10, a regulatory 
cytokine was significantly reduced at 5dp.i. in comparison to its level at 3dp.i. in Clec4d
-
/-
 miceThis was in contrast to other cytokines and chemokines whose levels continued to 
increase or stayed at similar high levels through day 5p.i. in these mice. In light of a 
recent study implicating STAT-1 regulated IL-10 production in resolution of KPn 
pneumonia [127], reduced level of this cytokine, either due to depletion of IL-10 
producing cells in Clec4d
-/-
 mice or due to the role of this receptor in continuous 
production of this cytokine in a positive feedback loop manner, possibly plays a role in 
lack of resolution in these mice. Notwithstanding the mechanism, our results show that 
Clec4d
-/-
 mice do not display a defect in their ability to mount an inflammatory response 
but rather display a hyperinflammatory phenotype akin of cytokine storm typically 
associated with sepsis. Moreover, levels of sepsis marker mediators such as Factor VII, 
C-reactive protein and fibrinogen were also massively increased in these mice (data not 
shown). Importantly, in the absence of Clec4d, these mice are unable to resolve the 
infection and the resulting inflammation. This further indicates a protective role of this 
receptor in resolution of KPn pneumonia.  
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Next, H&E staining was performed to determine immunopathological changes in WT and 
Clec4d
-/- 
mice. As shown in Fig. 10B, mock control WT and Clec4d
-/-
 mice display 
similar normal lung tissue morphology. A moderate peribronchial and perivascular 
infiltration of immune cells was observed in WT mice, which was reduced substantially 
by 5dp.i. The overall architecture of the lungs was largely preserved in the WT animals 
throughout the infection. The Clec4d
-/-
 mice, on the other hand, displayed a moderate 
immune cell infiltration for initial 2 days after infection. However, at later time points 
these mice exhibited much more severe pathological changes in their lungs with 
progressive increase in leukocytes (mainly neutrophils, as depicted by multilobed nuclear 
morphology in high magnification inset) infiltration through 3dp.i. By day 5 p.i., a time 
when the mice had become moribund, extensive foci of consolidation were visible with 
massive accumulation of neutrophils around alveolar spaces. Flow cytometry analysis of 
infiltrating cells in lungs showed that the numbers of Ly6G+CD11b+ neutrophils were 
significantly higher in the Clec4d
-/-
 lungs at 3dp.i. in comparison with the WT (Fig. 10C). 
Interestingly, the Clec4d
-/-
 mice showed a significantly increased number of neutrophils 
even at 2 p.i., a time when the bacterial burden was similar in the Clec4d
-/-
 and WT lungs. 
In order to further determine if these neutrophils were defective in bacterial clearance in 
the absence of Clec4d, phagocytosis of GFP-labeled KPn was compared between WT 
and Clec4d
-/-
 neutrophils by flow cytometry (as described in methods). As shown in Fig. 
11A, Clec4d deficiency had no effect on phagocytosis of opsonized or non-opsonized 
bacteria. Furthermore, these neutrophils showed a similar bacterial killing ability as their 
WT counterparts (Fig. 11B). This indicated that Clec4d likely does not play a direct role 





Figure 10. Pneumonic Clec4d
-/- 
mice exhibit hyperinflammatory response and severe 
lung pathology characterized by massive neutrophil accumulation.  
(A). The lungs from mock control and KPn infected WT and Clec4d
-/-
 mice were 
harvested at indicated time points post-infection, homogenized in PBS with protease 
inhibitors and analyzed for rodent multi-analyte profile (Myriad
TM
 Rules-Based 
Medicine, Austin, TX). Results shown are average of three infected and three mock 
control mice from 3 independent experiments. Significant differences are denoted by 
asterisks (*, p<0.05; **, p<0.005, ***p<0.001). (B). H&E staining of lung cryosections 
from mock control and KPn infected WT and Clec4d
-/-
 mice isolated at indicated times 
post-infection. Magnification 100X. Inset shows a highly magnified area (1000X) of a 
lesion in infected Clec4d
-/-
 depicting neutrophils as indicated by characteristic multilobed 
nuclear morphology. (C). Flow cytometry analysis of neutrophils in mock control (WT-
M and Clec4d
-/-
-M) and KPn infected (WT-Inf and Clec4d
-/-
-Inf) WT and Clec4d
-/-
 mice. 
Total lungs cells were isolated from mice by collagenase treatment at indicated times p.i.. 
The cells were stained with anti-Ly6G-APC and anti-CD11b-Pacific Blue antibodies as 
markers for neutrophils. Appropriate isotype matched negative controls were used to set 
the gates. The bar graph shows average of total number of neutrophils in lungs of three 
mock control and three KPn infected WT and Clec4d
-/-
 mice from 3 independent 
experiments (total 9 mice per group). Dot plots shown on the right are representative of 
three mice per group in 3 independent experiments. Statistical significance between WT 





Figure 11. Clec4d deficiency does not impair neutrophil phagocytosis and killing of 
bacteria but leads to their unbridled accumulation and activation.  
(A). Peritoneal neutrophils from WT and Clec4d-/- mice were incubated with GFP 
(Green Fluorescent Protein)-labeled KPn with (opsonized) or without (non-opsonized) 
10% normal mouse serum for 1 hour followed by quantitation of phagocytosis by flow 
cytometry. The results are expressed as % cells positive for fluorescent bacteria.  (B). 
Bacterial uptake and killing capacity of Clec4d-/- and WT neutrophils was determined at 
1h and 3h by assessing intracellular CFUs in these cells as described in Methods. The 
experiment was repeated 3 times with similar results. (C). The lungs from mock control 
and KPn infected WT and Clec4d
-/-
 mice were harvested at indicated time points post-
infection, homogenized in PBS with protease inhibitors and analyzed commercially for 
neutrophil associated immune mediators using rodent multi-analyte profile (Myriad
TM
 
Rules-Based Medicine, Austin, TX). Results shown are average of three infected and 
three mock control mice from 3 independent experiments. Significant differences are 






mice is not a secondary effect resulting from a defective bacterial clearance in the 
absence of this CLR. On the other hand, neutrophil chemoattractants (CXCL1 and 
CXCL6), neutrophil survival mediator (GM-CSF) and neutrophil activation markers 
(MMP9, MPO) were significantly higher in Clec4d
-/-
 mice, as compared to their WT 
counterparts (Fig. 11C). These results show that Clec4d is likely involved in neutrophil 
turnover and the absence of Clec4d results in greater and prolonged accumulation of 
neutrophils in lungs of mice. The persistent activation of these neutrophils is leading to 
greater lung pathology observed in Clec4
-/-
 mice as compared to their WT counterparts 
where the neutrophils infiltrate transiently and are cleared off as the infection resolves. 
These observations clearly suggest that while deficiency of Clec4d does not impair 
infiltration, bacterial phagocytosis and activation of neutrophils, this CLR is required for 
resolution of inflammation by way of facilitating neutrophil turnover.  
Resolution of inflammation is an active and tightly controlled process which is necessary 
for restoration and maintenance of tissue homeostasis. Deregulation of this process is the 
root cause of many diseases. Our results indicate that deficiency of Clec4d in an 
otherwise sublethal pulmonary KPn infection leads to a non-resolving, 
hyperinflammatory response which culminates in the death of infected KO animals. This 
report, for the first time shows that Clec4d likely plays a role in resolution of 
inflammatory response. Neutrophil mediated responses are essential for combating 
pneumonic bacterial infection and their protective role in sepsis and KPn infection in 
particular has been described elegantly [126,128]. However, persistent accumulation of 
neutrophils can lead to bystander tissue destruction, owing to their tissue destructive 
cargo. Accumulation of large numbers of neutrophils in the lungs of KO mice and higher 
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amounts of their associated inflammatory mediators suggests that there is a defect in 
neutrophil turnover in these mice. Since Clec4d was found not to be directly involved in 
bacterial uptake and killing by neutrophils, it seems more likely that due to the wide-
spread tissue damage owing to persistent neutrophil activity in the Clec4d
-/-
  mice, other 
immune cells important for bacterial clearance are depleted leading to this increase in 
local bacterial burden as well a systemic spread. Thus an increased bacterial burden 
(secondary to the defect in neutrophil turnover) is likely a factor contributing to the 
increased mortality of these mice eventually. As the neutrophil turnover and resolution of 
neutrophil associated responses is a complex process involving apoptosis and clearance 
of their contents (efferocytosis) and class-switching of lipid mediators, we are currently 
investigating the role of Clec4d in these processes.  
This study shows that Clec4d plays an important role in mitigating the inflammation 
during a pneumonic infection, possibly by facilitating neutrophil turnover. This study 
opens up new avenues of research on the role of Clec4d in resolution of inflammatory 
responses. This can have major implications in the therapeutic measurements of 
inflammation associated disorders. 
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Sepsis is a complex immune disorder that is characterized by systemic 
hyperinflammation. Alarmins, which are multifunctional endogenous factors, have been 
implicated in exacerbation of inflammation in many immune disorders including sepsis. 
Here we show that Galectin-9, a host endogenous β-galactoside binding lectin, functions 
as an alarmin capable of mediating inflammatory response during sepsis resulting from 
pulmonary infection with Francisella novicida, a Gram negative bacterial pathogen. Our 
results show that this galectin is upregulated and is likely released during tissue damage 
in the lungs of F. novicida infected septic mice. In vitro, purified recombinant galectin-9 
exacerbated F. novicida-induced production of the inflammatory mediators by 
macrophages and neutrophils. Concomitantly, Galectin-9 deficient (Gal-9
-/-
) mice 
exhibited improved lung pathology, reduced cell death and reduced leukocyte infiltration, 
particularly neutrophils, in their lungs. This positively correlated with overall improved 
survival of F. novicida infected Gal-9
-/- 
mice as compared to their wild-type counterparts.  
Collectively, these findings suggest that galectin-9 functions as a novel alarmin by 






Systemic hyperinflammation is the underlying cause of many immune inflammatory 
diseases, including sepsis. Despite more than three decades of active research, severe 
sepsis and septic shock remain major healthcare challenges with a mortality rate of 20-
50% and no effective therapy [5]. During sepsis, overwhelming and sustained release of 
pro- as well as anti-inflammatory cytokines, termed cytokine storm, causes extensive 
tissue damage and wide-spread cell death, eventually resulting in death. Despite the 
identification of cytokine circuitry as major determinants of mortality, pro-inflammatory 
cytokine blockade has been ineffective as therapy for sepsis. This indicates the 
involvement of additional mediators that are likely acting as regulators and/or 
perpetuators of this hyper inflammatory response. 
Alarmins are evolutionarily conserved endogenous molecules that perform homeostatic 
functions when contained within cellular compartments [29]. However, under 
pathological conditions, these molecules can be released either passively from dead cells 
or actively via non-classical secretion pathways [84]. Once in the extracellular milieu, 
they exhibit immune modulatory properties such as induction of pro-inflammatory 
cytokines, immune cell chemotaxis, and regulation of cell death [29]. In fact, a sustained 
and excessive release of alarmins has been shown to contribute to pathogenesis of several 
sterile as well as infectious inflammatory conditions [129,130]. Pertaining to their ability 
to impact innate immune cells such as macrophages, dendritic cells and neutrophils, 
alarmins also represent a crucial link between innate and adaptive immune responses, and 




Francisella is a highly virulent bacterial pathogen that causes an acute lethal disease 
called tularemia in humans and mice. Although there are strain-dependent differences in 
the initial mechanisms involved [131,132], our studies have shown that pulmonary 
infection of mice with fully virulent Francisella tularensis as well as the murine model 
organism F. novicida (F.n.) leads to development of severe sepsis characterized by 
hyperinflammation, T cell depletion, and extensive cell death in systemic organs 
[73,77,78]. As pulmonary infections are a major cause of sepsis [76], we are using a 
murine inhalation model of F.n. infection to understand the mechanism/s responsible for 
pulmonary infection-induced sepsis development. A recent report of an F.n. outbreak in a 
correctional facility suggests that this strain may be more virulent to humans than initially 
surmised, supporting its relevance as a model strain to understand pathogenesis [133].   
Furthermore, studies from our and other laboratories have shown that extensive tissue 
damage and wide-spread cell death is a hallmark of Francisella infection, regardless of 
the bacterial strain [78,80,81]. Additionally, our studies show that Francisella infected 
macrophages are defective in clearance of dead cells, a process termed efferocytosis, 
leading to accumulation of these dead cells and their progression to secondary necrosis 
[74]. It is thus likely that alarmins released from these dead or dying cells contribute to 
the inflammatory response culminating in sepsis development during respiratory 
infection with Francisella. We and others have reported an alarmin-mediated regulation 
of the inflammatory response during pulmonary infections [1,134,135].   However, in a 
complex immune disorder like sepsis which is an interplay of several host immune 
pathways such as the coagulation system, complement cascade and even the autonomic 
nervous system [26], several alarmins may be involved at the intersections of these 
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pathways. Thus, identification of additional alarmins will present therapeutic targets that 
may have more tangible translational potential when used in combination.     
Galectins, mammalian β-galactoside binding lectins, are emerging as potent immune 
regulators in a variety of pathological processes including inflammation, autoimmunity, 
fibrosis, and cancer [88,121]. Curiously, some galectins (galectin-1 and -3) have been 
shown to be secreted in the extracellular milieu via a non-classical ER/Golgi-independent 
pathway, where they exert immune modulating effects on immune cells. This is a 
characteristic feature of alarmins [136,137]. However the contribution of galectins as 
alarmins to sepsis development is poorly understood. In this study we have investigated 
the role of galectin-9, in the F.n. induced inflammatory response and sepsis. Our analyses 
of galectin-9 expression, distribution, immune modulation and comparison of disease 
progression in F.n. infected galectin-9 sufficient and –deficient mice show that galectin-9 
acts as an alarmin to exacerbate the inflammatory response in Francisella infection 
induced sepsis development.  
Materials and Methods 
Ethics Statement 
The animal usage protocols were approved by the Institutional Animal Care and Usage 
Committee at the University of North Dakota (protocol no. 1108-3). All procedures 
strictly followed the institutional and federal guidelines and all efforts were made to 
minimize the animal suffering. 
Bacterial strains and Mice 
The F.n. strain U112 was grown on Trypticase Soy Agar (TSA) medium supplemented 
with L-cysteine at 37
o
C. After overnight growth, the bacteria were harvested and 
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suspended in a freezing medium (250 mM sucrose, 10 mM sodium phosphate pH 7.2 and 
5 mM glutamic acid). Aliquots of the stocks were frozen at -80
o
C for further use. The 
animal usage protocols were approved by the Institutional Animal Care and Usage 
Committee at the University of North Dakota. All procedures strictly followed the 
institutional and federal guidelines and all efforts were made to minimize animal 
suffering. In vivo experiments were performed using 6-8 wk old female C57Bl/6 wild-
type and Gal-9 
-/-
 mice. Gal-9 
-/-
 mice were kindly provided by Dr. Judy M. Teale, 
University of Texas at San Antonio (initially obtained from the Consortium of Functional 
Glycomics, Scripps, La Jolla) as F4 and were back-crossed for additional 6 generations. 
Sex- and age-matched Gal-9
+/+
 mice with the same genetic background were used as 
controls.  
Antibodies and Reagents  
All reagents were purchased from Sigma-Aldrich unless otherwise indicated. For 
detection of galectin-9 by immunofluorescence (IF) staining, a purified rat galectin-9 
antibody (Abcam, San Diego, CA) followed by Alexa-546 conjugated chicken anti-rat 
antibody (Molecular Probes, OR) was used.  A rat anti-mouse CD11b antibody 
conjugated to PE (BD Pharmingen) and a purified rat anti-mouse Ly-6G (Clone Accurate 
Chemical, Westbury, NY, USA) followed by chicken anti-rat Alexa488 (Molecular 
Probes, OR) were used for detection of activated neutrophils by IF staining. For flow 
cytometry Pacific Blue
TM
 anti-mouse CD11b and APC anti-mouse Ly6G (Clone 1A8) 
antibodies (Biolegend, San Diego, CA) were used. The terminal deoxyribonucleotidyl 
transferase-mediated triphosphate (dUTP)-biotin nick end labeling (TUNEL) staining kit 
was purchased from Chemicon International, CA. Purified recombinant galectin-9 was 
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purchased from R&D Systems, MN.  The endotoxin level was <1.0 EU per µg of protein. 
Ultrapure E. coli endotoxin was purchased from Invivogen and lactose was purchased 
from Sigma. For detection of reactive oxygen species, Fc OxyBURST assay reagent was 
purchased from Molecular Probes, Eugene, OR. Mouse IL-6 ELISA kits (BD OptEIA) 
were from BD Biosciences, San Diego, CA.   
Infection of Mice, survival and bacterial burden   
Mice were anaesthetized using a mixture of ketamine HCL and xylazine (30mg/ml 
ketamine, 4 mg/ml xylazine in PBS) and were infected intranasally with 50-70 CFUs of 
the F.n. strain U112 in 20 μl of PBS or with 20 µl of PBS alone. The mice were 
monitored daily. The survival of infected mice (15 mice each WT and Gal-9
-/-
 in 3 
independent experiments) was recorded for up to 2 weeks post-infection (p.i.). The death 
was recorded as tularemia induced mortality.  Mice displaying severe signs of distress 
(labored breathing, non-responsiveness to cage tapping, failure of grooming and severe 
eye discharge) were humanely sacrificed by injecting a mixture of ketamine (90-
120mg/kg) and xylazine (10mg/kg) followed by cervical dislocation. In some 
experiments, the mice were euthanized at indicated times p.i. and blood, lungs, liver and 
spleen were aseptically harvested. The organs were homogenized aseptically in cold PBS 
with Complete
TM 
protease inhibitor cocktail (Roche Diagnostics, Germany). For the 
bacterial burden analyses, the homogenates and blood were serially diluted in PBS and 







Quantitative real-time PCR 
Lungs from infected and mock control mice at various times p.i. were removed 
immediately after perfusion and total RNA was extracted using Trizol reagent 
(Invitrogen) according to the manufacturer’s instructions. Real-time PCR analysis of the 
samples was performed using SYBR green (Applied Biosystems, CA, USA) as described 
by us [1]. Transcript levels of the housekeeping ribosomal 18S and galectin-9 genes were 
measured in each sample by PCR amplification using specific primers: 18S (forward) 5'-
CATGTGGTGTTGAGGAAAGCA-3' and (reverse) 5'-
GTCGTGGGTTCTGCATGATG-3'; Gal-9 (forward) 5'- 
TCAAGGTGATGGTGAACAAGAAA-3’ and (reverse) 5’- 
GATGGTGTCCACGAGGTGGTA -3’. The target gene expression levels were 
normalized to those of the house keeping 18S gene in the same sample. Expression of 
galectin-9 in infected samples was determined as fold change over that in control samples 
calculated by using the formula 2
−(ΔΔCt)
.  
Histological and Immunofluorescence staining 
For histological and immunofluorescence staining, frozen lung tissues were processed as 
previously described [77]. Lung cryosections thus obtained were stained with 
hematoxylin and eosin (H&E) for pathological analysis, or for the detection of galectin-9 
by immunofluorescence staining, as previously described [89]. Semi-quantitative 
histopathology was performed as described previously in [138]. For the detection of cell 
death, TUNEL method was used according to manufacturer’s instructions (Chemicon 
International, CA). The images were acquired using a Nikon Eclipse fluorescent 
74 
 
microscope with an attached SPOT II digital camera. The images were processed and 
analyzed using Adobe Photoshop 7.0 software (Adobe, Mountain view, CA).  
Flow cytometry 
Lungs were harvested from the infected and mock control mice at 3 days p.i. (dpi) after 
perfusion with PBS and were treated with collagenase to obtain single cell suspensions as 
previously described [77,78]. Cells were then co-stained with anti-CD11b and -Ly6G 
antibodies. FlowJo (Tree Star) software was used to analyze data.  
Multi-analyte profile analysis 
The lung homogenates were prepared as described for the bacterial burden analysis above 
and were centrifuged at 2000 x g for 15 min to clear cellular debris. The supernatants 
were immediately frozen at -80
o 
C. The biomarker levels in lung homogenates were 
determined commercially by Myriad Rules-based Medicine (Austin, TX, USA) utilizing 
a multiplexed flow-based system: Mouse MAP
TM
 (Multi-Analyte Profiles) analysis 
technology. 
Neutrophil and macrophage activation  
Cells were isolated from the peritoneal cavities of naïve C57BL/6 mice 12-14h after 
intraperitoneal injection of sterile 4% thioglycollate. Non-adherent neutrophils were 
plated at the density of 1x10
6
 cells and were infected with wild-type F.n. strain U112 at 
MOI 50 with or without pretreatment of the cells with 15µg/ml of purified recombinant 
galectin-9.  Cells stimulated with galectin-9 alone or with 10ng/ml of phorbol myristate 
acetate (PMA) served as controls. One hour after stimulation, production of reactive 
oxygen species (ROS) was measured in the cells by flow cytometry using Fc OxyBURST 
reagent according to the manufacturer’s instructions. A minimum of 20,000 events were 
read for each sample and all the cells fluorescing positive in FITC channel (excitation and 
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emission maxima of ~490 nm and ~520 nm, respectively) were gated to obtain the 
percentage of ROS producing cells. 
 Bone marrow was isolated from wild-type and Gal-9
-/-
 mice and the cells were 
differentiated to macrophages as previously described [91]. On day 6 of culture, the cells 
were plated at 8×10
4
 cells / well in 96-well flat-bottom plates and were stimulated with 
galectin-9 with or without 25mM lactose. As a control for endotoxin contamination, 
recombinant galectin-9 or UltraPure LPS boiled for 45 min at 100 °C were used to 
stimulate cells. Culture supernatants were collected 24h after stimulation and IL-6 levels 
were measured by ELISA according to the manufacturer’s instructions (BD OptEIA, BD 
Biosciences).  
Statistical Analysis 
Statistical analysis of survival studies was performed by Kaplan Meir log-rank test; 
bacterial burdens by non-parametric Mann-Whitney Test. All other statistical analyses 





Galectin-9 is upregulated and released during the septic phase of F.n. infection.   
We and others have previously shown that extensive cell death is a hallmark of 
pulmonary Francisella infection, regardless of the bacterial strain used (8, 9, 21-23). 
Factors released from dead or dying cells, termed as alarmins, have been shown to exhibit 
inflammatory, chemoattractant and immune activating properties in various pathological 
conditions. To test our hypothesis that galectin-9 functions as an alarmin, we first 
analyzed the expression and distribution of galectin-9 in the lungs of mice undergoing 
pulmonary infection with F.n. As shown in Figure 12A, galectin-9 transcript levels 
progressively increased in the lungs of infected mice and reached the highest levels at 
3dpi. This increase in galectin-9 expression at 3 dpi is consistent with the appearance of 
other sepsis features (extensive cell death, hyperinflammatory response, increased 
vascular injury) at this time, as reported in our previous studies with F.n. as well as the 
fully virulent F. tularensis [77,78]. Immunofluorescence (IF) analysis of galectin-9 
protein expression in cryosections of the lungs harvested at this septic phase showed a 
low basal level of galectin-9 in mock control mice inoculated with PBS alone (Fig. 12.B). 
F.n. infected mice, on the other hand, exhibited very high galectin-9 expression in their 
lungs. Furthermore, galectin-9 could be detected in cell-free areas, especially in the 
lesions with massive cellular infiltration, indicating that it is likely released 
extracellularly (Fig. 12.B lower panel and inset). Together, these data suggested that 
galectin-9 likely exhibits a characteristic alarmin property of extracellular release during 
septic phase of pulmonary F.n. infection.    
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Figure 12. Galectin-9 is upregulated and released in lungs of mice during 
respiratory F. novicida (F.n.) infection.  
(A) Total RNA was extracted by Trizol method from lungs harvested at the indicated 
times after infection with the F.n. strain U112. The mRNA levels of galectin-9 were 
analyzed by real-time PCR as described in Materials and Methods and are expressed as 
fold increase over the levels in mock control mice. Data shown are the averages of 3- 4 
mice per group. (B) In-situ IF staining of frozen lung sections from mock control and 
U112 infected mice harvested at 3 dpi.  The sections were stained for galectin-9 (red) 
using a purified rat galectin-9 antibody followed by Alexa-546 conjugated chicken anti-
rat antibody. Nuclei (blue) were stained with 4’6’ diamidino-2-phenylindol-dilactate 
(DAPI). Magnification X 200. Inset depicts possible extracellular galectin-9 in infected 
mouse lungs. The area indicated by green arrow has been enlarged and shown in (C). 






Galectin-9 deficiency ameliorates lung pathology in F.n. infected mice  
In order to assess the role of galectin-9 in overall disease severity during tularemia, we 
next examined H&E stained lung cryosections from F.n. infected wild-type (WT) and 
Gal-9
-/-
 mice. Consistent with our previous studies, a progressive increase in cellular 
infiltration was observed in the F.n. infected WT mice with extensive pathology, severe 
bronchopneumonia and massive cell death, occurring in the center of large granuloma-
like areas of infiltration at 3 dpi (Fig. 13.A upper panel).  The lungs of Gal-9
-/- 
mice, on 
the other hand, showed a substantial delay in the cellular infiltration with moderate 
peribronchial and perivascular infiltration by 3dpi (Fig. 13.A lower panel).  Although 
these mice displayed an increased cellular infiltration at 5dpi, the lesions appeared much 
smaller in the lungs of Gal-9
-/-
 mice as compared to those in the WT mice. 
Concomitantly, the Gal-9
-/- 
mice exhibited significantly lower pathological score in 
comparison with their WT counterparts at all the time points tested (Fig. 13.B).  Mock 
infected WT and Gal-9
-/- 
mice exhibited similar normal lung architecture with minimal 
cellular infiltration and clear air spaces (data not shown). As alarmins are released 
passively from dead cells, we analyzed the extent of cell death in the lungs of infected 
WT and Gal-9
-/-
 mice by TUNEL assay. As shown in Figure 13C, septic lungs of F.n. 
infected WT mice showed extensive cell death, indicated by a large number of TUNEL 
positive cells within perivascular and peribronchial lesions. In contrast, infected Gal-9
-/-
 
mice exhibited significantly fewer TUNEL positive cells in their lungs (Fig. 13.C). The 
improved lung architecture and reduced cell death in the absence of galectin-9 indicates a 





 mice exhibit improved lung pathology and reduced TUNEL 
staining indicative of cell death upon pulmonary F.n. infection.  
(A) The lungs from F.n. infected wild-type (WT) or Gal-9-/- mice were harvested at 
indicated times post-infection, embedded in optimal-cutting-temperature (OCT) 
compound, and sectioned as described in Materials and Methods. The frozen sections 
were stained with Hematoxylin and Eosin (H&E). The images obtained are 
representatives of three experiments performed with 3 mice per group in each 
experiment.  Magnification, ×200.  (B) H&E sections were scored in blinded fashion 
according to the following scoring scale: 0, no inflammatory cells (macrophages or 
neutrophils) present in section; 1, <5% of section infiltrated by inflammatory cells; 2, 5–
10% of section infiltrated; 3, 20% of section infiltrate; and 4, >20% of section infiltrated. 
(C) Frozen lung sections from F.n. infected WT or Gal-9-/- mice were processed for in-
situ TUNEL staining for detection of DNA fragmentation (red) in nuclei. Nuclei (blue) 
were stained with 4′,6′-diamidino-2-phenylindole dilactate. Bar graph shows Mean 






Galectin-9 regulates cellular infiltration and inflammatory response in vivo during F.n. 
infection 
Alarmins exert their immune stimulatory effects by mediating immune cell infiltration 
directly or indirectly, and by predisposing the cells to produce increased levels of 
inflammatory mediators in response to infection. We hypothesized that; similar to the 
function of alarmins, increased expression and extracellular localization of galectin-9 
may be contributing directly or indirectly to the increased cellular infiltration and 
hyperinflammatory response observed during pulmonary Francisella infection.  Previous 
studies from our and other laboratories have shown that neutrophils are the predominant 
cell type infiltrating in F.n. infected WT mice [77,78,94,139]. In order to compare 
neutrophil infiltration in the lungs of Gal-9
-/-
 and WT mice infected with F.n., IF staining 
and flow cytometry was performed. Consistent with our previous studies, lungs of the 
infected WT mice showed extensive infiltration of CD11b+ Ly6G+ neutrophils that 
accumulated largely in the lesions (Fig.14.A and B). The numbers of Ly6G+CD11b+ 
cells in Gal-9
-/-
 mice, on the other hand, were significantly reduced (Fig.14.A and B). 
These results suggested a role of galectin-9 in regulation of neutrophil accumulation in 
the lungs of mice during pulmonary F.n. infection.  Furthermore, analysis of the levels of 
inflammatory cytokines and neutrophil-associated mediators in the lungs revealed 
significantly reduced levels of TNF-α, IL-6, myeloperoxidase (MPO), matrix 
metalloproteinase-9 (MMP-9) and GM-CSF, in the infected Gal-9
-/-
 mice (Fig.14.C). 
Together, these results suggested a putative role of galectin-9 in neutrophil accumulation 





 mice display reduced accumulation of neutrophils and reduced 
inflammatory mediators in lungs during F.n. infection.  
(A) Frozen sections of lungs harvested at 3 dpi  from F.n. infected WT or Gal-9-/- mice 
were co-stained with antibodies against myeloid cell markers CD11b (red) and Ly6G 
(green). A high co-expression of both markers is depicted by yellow color and indicates 
neutrophils. Nuclei (blue) were stained with 4’6’ diamidino-2-phenylindol-dilactate 
(DAPI). Magnification X 200.  Asterisks depict lesions in the lungs. (B) Flow cytometry 
analysis of neutrophils in mock control and F.n. infected WT and Gal-9
-/-
 (WT-Fn and 
Gal-9
-/-
-Fn) mice. Total lungs cells were isolated from mice by collagenase treatment at 3 
dpi as described in Methods. The cells were stained with anti-Ly6G-APC and anti-
CD11b-Pacific Blue antibodies as markers for neutrophils. The plots are representative of 
three mice per group in 3 independent experiments. (C) Lungs from mock infected and 
F.n. infected WT or Gal-9
-/-
 mice were harvested at 3dpi, homogenized with protease 
inhibitors in PBS and analyzed commercially for rodent multi-analyte profiles (Myriad 
Rules-Based Medicine, Austin, TX). Levels of inflammatory cytokines and neutrophil 
markers in lung homogenates are shown. Results shown are from 3-4 mice per group 
from 3 different experiments. MMP-9; matrix metalloproteinase 9, MPO; 
myeloperoxidase. * p<0.05; ** p<0.005; *** p<0.001. Comparisons were made between 
infected WT and Gal-9
-/- 






Galectin-9 exacerbates F.n. infection induced inflammatory response in vitro  
To examine the direct effect of galectin-9 on activation of neutrophils and macrophages, 
two cell types playing a predominant role in tularemia pathogenesis, we next carried out 
in vitro stimulation of these cells with recombinant galectin-9 protein with or without F.n. 
infection. While stimulation with purified galectin-9 or U112 infection alone moderately 
induced ROS production in peritoneal neutrophils, pre-treatment of neutrophils with this 
lectin induced an increased amount of ROS in response to F.n. infection, which was 
significantly higher than that elicited by galectin-9 or F.n. infection alone (Fig.15.A). 
Stimulation of bone marrow derived macrophages (BMDMs) with galectin-9 alone or 
galectin-9 and U112 together elicited a significantly higher IL-6 production than U112 
alone. (Fig. 15.B).  This immune stimulatory effect of galectin-9 was abolished upon 
heat-denaturation or by addition of 25mM lactose to the cultures, confirming the 
specificity of this activity. These observations indicated that while galectin-9 by itself can 
stimulates myeloid cells, particularly macrophages, it can also augment Francisella 
infection-induced myeloid cell activation which likely has implications in exacerbation of 
inflammation culminating in sepsis development during this infection.   
Gal9
-/-
 mice show improved survival following F.n. infection. 
In order to correlate the improved lung pathology and reduced inflammatory responses 
with the disease outcome, overall disease severity and survival was compared in WT and 
Gal-9
-/-
 mice infected with F.n. In the infected WT mice, visible signs of disease started 
to appear by 3 dpi which typically included piloerection, hunched gait, lethargy, and eye 
discharge. All of these mice succumbed to infection by day 6 p.i. (Fig. 16.A). By contrast
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Figure 15.  Galectin-9 regulates F.n. infection induced inflammatory response in 
vitro.  
(A). Peritoneal neutrophils were isolated from mice 12-14h after injection with 4% 
thioglycollate and were stimulated with F.n. at an MOI 50 with or without pre-treatment 
with purified recombinant galectin-9 (15µg/ml). Stimulation with galectin-9 alone or 
phorbol myristate acetate (PMA, 10ng/ml) was used as a control. Production of reactive 
oxygen species (ROS) was measured one hour post-stimulation by flow-cytometry using 
Fc-OxyBURST dye following the manufacturer’s instructions. Numbers below the plots 
depict average percent of ROS positive cells from 3 independent experiments. Plots from 
a representative of these 3 independent experiments are shown. (B) Bone marrow 
derived macrophages (BMDMs) from C57Bl/6 wild-type mice were stimulated with F.n. 
Strain U112 at an MOI of 50 with or without pretreatment with 15µg/ml of purified 
recombinant galectin-9. UltraPure E.coli LPS (10ng/ml) and galectin-9 with and without 
heat-denaturation (boiled at 100
o
C for 45 min) as well as competitive inhibition with 
lactose (25mM) were used as controls to test the specificity of galectin-9 effect, as 
described in methods. Culture supernatants were collected 24h after infection and the 
amount of IL-6 was measured by ELISA. The data shown is average of three independent 
experiments.  Statistical analysis between the data sets was performed by Two-way 








 mice exhibited delayed appearance of disease symptoms and showed 
significantly improved survival as compared to the infected wild-type mice (Fig.16.A). 
The improved survival of Gal-9
-/-
  mice, however, did not correlate with bacterial burdens 
in their lungs, spleen and liver since similar bacterial load was observed in WT and KO 
mice (Fig. 16.B). Intriguingly, Gal-9
-/-
 mice exhibited significantly lower bacterial counts 
in their blood at 2dpi than their WT counterparts at that time point indicating a delayed 
development of bacteremia in the absence of galectin-9. However, the bacterial burden in 
blood was similar in infected WT and Gal-9
-/-
 mice at later time points indicating that 
once hematogenous, bacteria replicated at similar rates in both strains.   
Discussion 
 In this study we examined the role of galectin-9, a mammalian β-galactoside binding 
lectin, in the development of sepsis during pulmonary infection with F. novicida. We 
report the upregulation and extracellular release of galectin-9 during F.n. infection and its 
ability to amplify Francisella infection-induced inflammatory response as well as 
concomitant improved disease severity of Gal-9
-/-
 mice. These functions of galectin-9 are 
all consistent with characteristic properties of alarmins that have been described to play a 
pathological role in perpetuation of inflammation.  
Sepsis is characterized by a complex, systemic inflammatory response to a traumatic or 
infectious insult, such as F.n. infection in the current study. Mechanisms of innate 
immune activation in sepsis are no longer thought be induced exclusively by components 







 mice show improved survival during pulmonary F.n. infection.  
(A) Fifteen each C57Bl/6 WT and  Gal-9-/- mice in 3 separate experiments (5 mice per 
experiment) were inoculated intranasally with F.n and were monitored daily for 2 weeks. 
The improved survival of Gal-9
-/-
 mice compared to WT mice was statistically 
significant, as determined by Kaplan-Meier log-rank analysis (P value*** = 0.0003). (B) 
Bacterial burdens in lungs, blood, spleen and liver harvested from F.n. infected WT and 
Gal-9
-/-
 mice at indicated times post-infection. Lung, liver and spleen homogenates 
prepared as described in Materials and Methods and blood were serially diluted and 
plated on TSA plates to enumerate bacterial burdens. Each symbol on the plots represents 
one mouse and data is from 2-3 independent experiments.  
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multifunctional host proteins, have been shown to regulate inflammatory response in 
many pathological conditions including sepsis, upon their release from dead/dying host 
cells [32,33,96]. High Mobility Group Box1 (HMGB-1), S100 family of proteins, and 
heat shock proteins are among the most well-characterized alarmins to date [84], 
although the list of alarmins has continued to grow over the past decade [140]. Indeed, in 
a complex immune disorder like sepsis, it is likely that several alarmins are involved at 
the intersections of various pathways. Our current study shows that galectin-9, a host 
lectin, plays a pathogenic role as an alarmin to exacerbate the inflammatory response 
during pulmonary infection with Francisella and contributes to sepsis development.  
Identification of novel alarmins such as galectin-9 may aide in understanding this 
complex disorder and may present additional targets for effective therapeutics.  
Galectins are ubiquitously expressed β-galactose binding lectins. These constitute the 
only soluble mammalian lectins which are either passively released by dying cells or are 
actively secreted by inflammatory cells through a non-classical secretory pathway [66]. 
Although several galectins have been detected in the extracellular milieu [141], the 
precise mechanism of their secretion remains to be determined, since they lack a classical 
“leader” sequence. Galectins play homeostatic roles in regulation of cell cycle and 
apoptosis, phagosome formation, and stabilization of intracellular signaling when 
contained in intracellular compartments [63]. Some of these galectins such as galectin-1 
and -3 exhibit inflammatory and T cell apoptotic activities upon extracellular release 
[64].  Moreover, the extracellular release of some galectins seems to correlate with the 
virulence of invading pathogen [65,137] as well as influences immune responses through 
chemotaxis and activation of innate immune cells [64,66]. Despite the progress in our 
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understanding of the inflammatory properties of galectins, the role of these lectins as 
alarmins in the development of sepsis is not defined. Our results described here show, for 
the first time that galectin-9, mostly studied for its function as modulator of T cell 
immunity, is likely released extracellularly and modulates innate immune responses by 
affecting immune cell infiltration and activation during a septic infection by F.n.   
Although speculative at this stage, the reduced number of leukocytes in F.n. infected Gal-
9
-/-
 mice suggests that this lectin directly or indirectly affects cellular 
infiltration/accumulation in sepsis. To the best of our knowledge, there are no reports 
examining the impact of galectin-9 on innate cell infiltration during an acute pneumonic 
infection although, human galectin-9 has been identified as a potent eosinophil 
chemoattarctant with implications in allergic airway inflammation [142]. Galectin-9 has 
also been shown to induce IL-8 production by bronchial epithelial cells in cystic fibrosis, 
influencing neutrophil infiltration and early neutrophil-dominated inflammation in the 
cystic fibrosis lung [143]. Reduced levels of neutrophil chemoattractant and activation 
markers in Gal-9
-/-
 mice in our studies suggest that this lectin may exert its effect on 
cellular infiltration indirectly by modulating the levels of these chemokines. This 
observation is in line with the role of the prototypic alarmin HMGB1 in neutrophil 
migration by regulating the levels of chemoattractants such as IL-8 [99]. However it is 
also possible that galectin-9 influences neutrophil infiltration directly by binding to its 
receptor T cell Ig and mucin domain–containing molecule-3 (TIM-3) which was recently 
reported to be expressed by neutrophils [144]. Other proinflammatory alarmins such as 
S100 proteins have also been shown to directly promote migration of myeloid cells by 
binding to their cell surface receptors [101]. Further studies are needed to test these 
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hypotheses. Notwithstanding the mechanism, the reduced neutrophil accumulation in F.n. 
infected Gal-9
-/-
 animals indicates a likely chemotactic function of this lectin in F.n. 
induced sepsis.   
The role of galectin-9 in regulating T helper-1 responses via its interaction with TIM-3 
has been extensively studied. Galectin-9 interaction with TIM-3 on T cells results in cell 
death causing down regulation of pro-inflammatory Th1 responses implicated in 
pathology of autoimmune diseases such as EAE and GVDH [145-147]. However, its role 
in myeloid cell activation is much less defined. Recent studies have reported involvement 
of TIM-3/galectin-9 interaction in activation of neutrophils and macrophages [144,148]. 
Another study showed galectin-9 induced secretion of pro-inflammatory cytokines from 
monocytes and macrophages, that could amplify immunopathology associated with HCV 
infection [149]. Additionally, the effects of galectin-9 on activation and maturation of 
antigen presenting cells have been shown [150-152]. More relevant to our study, a recent 
study reported that galectin-9 mediates potentiation of TLR-ligation induced TNF-Α and 
IL-6 secretion from microglia [153]. This is similar to our observation of galectin-9 
mediated potentiation of F. novicida induced inflammatory response.  In our studies, 
consistent with the property of a typical alarmin, galectin-9 exhibited immune activating 
properties such as stimulation of the oxidative burst in neutrophils and inflammatory 
cytokine production in macrophages. Importantly, this lectin was able to augment F.n. 
infection induced inflammatory responses from neutrophils as well as macrophages, 
which can have important implications under in vivo conditions. Consistent with this pro-
inflammatory activity of galectin-9, Gal-9
-/-
 animals exhibited a reduction in the levels of 
inflammatory cytokines such as TNF-α, IL-6 and IL-1 during F.n. infection. Studies from 
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our laboratory have shown that pulmonary infection with F.n., as well as F. tularensis, 
results in extensive cell death [74]. It is likely that during pulmonary Francisella 
infection, galectin-9 released from dead cells primes the myeloid cells to produce 
heightened levels of inflammatory mediators in response to the bacteria. Furthermore, 
since galectin-9 can be upregulated and released from cells upon exposure to pro-
inflammatory stimuli such as cytokines and TLR ligands [154], the activated cells likely 
release more galectin-9 resulting in a positive feed-back loop causing further tissue 
damage and ultimately organ failure, characteristic of sepsis. This is also supported by 
our unpublished observations showing that bone marrow derived macrophages from Gal-
9
-/-
 mice show impaired activation upon stimulation with TLR-4 ligand LPS. This 
immune stimulatory activity of galectin-9 in the context of Francisella infection is in line 
with a previous study showing the role of the prototype alarmin HMGB1 in promoting 
the inflammatory response of monocytes elicited by external stimuli [98].  
As a result of mitigated inflammatory responses and tissue pathology, the survival of F.n. 
infected Gal-9
-/-
 mice was significantly improved as compared to the WT mice which 
succumbed to infection by day 5-6. Interestingly, we observed similar bacterial burdens 
in the lungs of F.n. infected Gal-9
-/-
 and wild-type mice. However, the bacteremia was 
delayed in Gal-9
-/-
 mice with significantly lower burden in blood at 2dpi but the 
difference at later points as was not statistically significant as compared to the WT mice. 
Galectin-9 has been shown to mediate phagocytosis of P. aeruginosa by neutrophils thus 
contributing to bacterial clearance [144]. In contrast, a similar bacterial burden in WT 
and Gal-9
-/-
 mice in our study indicates that galectin-9 does not play a role in F.n. 
clearance. Because of high bacterial burden, a majority of Gal-9
-/-
 mice ultimately 
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succumbed to infection. These results are similar to our recently published studies of 
galectin-3 function in F.n. induced sepsis.  In this scenario a combinatorial approach 
using blockade of galectin-3 and galectin-9 along with antibiotics could potentially treat 
Francisella infection induced sepsis. Additionally, in order to address any possible 
synergistic effect of galectin-3 and -9 (since we have found that these are the only two 
galectins, out of nine tested by us, which are upregulated and are likely released in 
Francisella infected lungs), we have already generated galectin-3/galectin-9 double 
knock-out mice and are currently analyzing them for sepsis development during bacterial 
infection. In light of a similar alarmin-like function of these galectins, the double knock-
out mice may exhibit further improvement in the disease outcome. 
Together our findings indicate that galectin-9 plays a pathogenic role as an alarmin to 
exacerbate the inflammatory response during pulmonary infection with Francisella and 
contributes to sepsis development. Galectin-9 thus may represent a potential target for 
treatment of sepsis during this infection.   
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Background: Nosocomial infections with Klebsiella pneumoniae (KPn) are a frequent 
cause of Gram-negative sepsis. To understand the functioning of host innate immune 
components in this disorder, we examined a previously uninvestigated role of C-type 
lectin receptor Mincle, in pneumonic sepsis caused by KPn.  
Methods: Disease progression in wild-type and Mincle
-/-
 mice undergoing pulmonary 
infection with KPn was compared.   
Results: While the wild-type mice infected with a sublethal dose of bacteria could resolve 
the infection with bacterial clearance and regulated host response, the Mincle
-/-
 mice were 
highly susceptible with a progressive increase in bacterial burden despite their ability to 
mount an inflammatory response which turned to an exaggerated hyperinflammation with 
the onset of severe pneumonia. This correlated with severe lung pathology with a massive 
accumulation of neutrophils in their lungs.  Importantly, Mincle
-/-
 neutrophils displayed a 
defective ability to phagocytize non-opsonic bacteria and an impaired ability to form 
extracellular traps (NETs), an important neutrophil function against invading pathogens, 
including KPn.  
Conclusion: Our results demonstrate protective role of Mincle in host defense against 
KPn pneumonia by coordinating bacterial clearance mechanisms of neutrophils. A novel 
role for Mincle in regulation of NETosis may have implications in chronic disease 




Lower respiratory tract infection with bacteria can lead to sepsis development, which is a 
complex immune disorder characterized by a systemic hyperinflammation. There are 
currently no effective therapies for sepsis that results in 750,000 hospitalizations annually 
in the United States with a mortality rate of 20-50% [5,155]. Nosocomial infections with 
opportunistic pathogen Klebsiella pneumoniae (KPn) account for 5-20% of Gram-
negative sepsis cases [117-119]. Additionally, emergence of multidrug resistant isolates 
of KPn in clinical settings is a serious health concern. As innate mucosal immunity plays 
a direct role in bacterial killing and immunomodulation in this acute infection [126,156-
159], an understanding of functioning of host innate immune components might provide 
targets for modulation of host immune system in a beneficial manner. 
Mincle is a C-type lectin receptor (CLR) belonging to the Dectin-2 subfamily of innate 
immune receptors that can function as an activating receptor for host- as well as 
pathogen-associated molecular patterns, termed alarmins and PAMPs respectively 
(reviewed in [49,160]. It is an inducible receptor, expressed mainly by myeloid cells such 
as macrophages, neutrophils, myeloid dendritic cells as well as some B-cell subsets [160-
162].  Functional analysis of this receptor in macrophages has received the most 
attention, where its association with FcRγ activates downstream signaling cascades 
involving Syk kinases resulting in induction of protective inflammatory response [163-
165]. While the function of Mincle in chronic bacterial infections such as tuberculosis 
and fungal infections was examined in these studies, its role in acute pneumonic 
infections leading to sepsis development has not been explored. Furthermore its functions 
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other than as an inflammatory PRR (Pattern Recognition Receptor) have received little, if 
any, attention.   
Neutrophil mediated responses are essential for combating pneumonic bacterial infection 
and their protective role in sepsis and KPn infection in particular has been described 
[128,138]. The professional antimicrobial program of neutrophils mainly constitutes 
phagocytosis of infectious agents followed by production of noxious agents such as 
reactive oxygen species which kill the internalized microbes. Another recently 
established mechanism of microbial killing by neutrophils is by formation of extracellular 
traps (termed neutrophil extracellular traps or NETs) which are DNA fibrils expelled by 
these cells that are decorated with granular contents such as various proteases and can 
ensnare and kill the microbes without phagocytosis [166-168]. Mincle has been shown to 
be expressed by neutrophils and while shown to play a role in neutrophil mediated 
protective responses against Candida and mycobacteria [169,170], its direct role in 
bacterial phagocytosis and NET formation is not known. Since neutrophils are a key cell 
type  in controlling KPn infection, Mincle signaling in neutrophils may be a key event in 
control of KPn infection and sepsis. 
In this study we examined the role of Mincle in acute KPn infection causing pneumonic 
sepsis. Our results suggest novel protective function of Mincle as non-opsonic phagocytic 
receptor for the bacteria and in regulation of neutrophil NET formation indicating the 
importance of this CLR in neutrophil-specific bacterial clearance mechanisms in 





Bacterial strains and Mice 
The KPn (ATCC strain 43826) were grown to log phase in LB medium at 37
o
C. All in-
vivo experiments were performed using 6-8 weeks old female wild-type C57BL/6 or 
Mincle
-/-
 mice on same background obtained from the Consortium of Functional 
Genomics, Scripps, La Jolla and bred in the animal facility of the University of North 
Dakota. The animals were used according to institutional and federal guidelines.  
Infection of Mice, survival and bacterial burden   
Mice were anaesthetized with a mixture of 30mg/ml ketamine and 4 mg/ml xylazine in 
PBS and were infected intranasally with sublethal dose (2.5 x 10
4
 bacteria in 20ul of 
saline, determined experimentally) of KPn or with 20 µl of saline alone. Survival of the 
mice was recorded for up to 2 weeks post-infection (p.i.). In some experiments, the mice 
were euthanized at indicated times p.i. and blood, lungs and liver were aseptically 
homogenized in cold PBS with Complete
TM 
protease inhibitor cocktail (Roche 
Diagnostics, Germany). For the bacterial burden analyses, serially diluted homogenates 
and blood were plated on LB agar and incubated at 37
o
C overnight.  
Quantitative real-time PCR 
Total RNA from lungs of infected and mock control mice harvested at various times p.i. 
was extracted using Trizol reagent (Invitrogen) according to the manufacturers' 
instructions. Real-time PCR analysis was performed using SYBR green (Applied 
Biosystems, CA, USA) to measure the expression levels of Mincle-specific mRNA by 
using specific primers (sense) 5'- ACC AAA TCG CCT GCA TCC -3' and (anti-sense) 
5'- CAC TTG GGA GTT TTT GAA GCA TC -3' (as described by us in [1].  The target 
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gene expression levels were normalized to levels of the house keeping 18S gene in the 
same sample. Expression of Mincle in infected samples was determined as fold change 
over that in control samples as calculated by using the formula 2
−(ΔΔCt)
. 
Multi-analyte profile analysis 
The lung homogenates were prepared as described for the bacterial burden analysis above 
and were centrifuged at 2000 x g for 15 min to clear cellular debris. The supernatants 
were immediately frozen at -80
o 
C. The biomarker levels in lung homogenates were 
determined commercially by Myriad Rules-based Medicine (Austin, TX, USA) utilizing 
a multiplexed analysis. 
Histological analysis 
For histological analysis, frozen lung tissues were processed as previously described 
[77,82]. Serial horizontal sections (10 µm thick) of frozen lung tissues thus obtained were 
stained with hematoxylin and eosin for pathological analysis as previously described 
[3,89] .  
Flow Cytometry  
Lungs or BAL cells were harvested from mice at 3 days p.i. and processed as previously 
described by us [77,78,82]. Enumeration of neutrophils by flow cytometry (using a BD 
LSR II, Becton Dickinson, San Jose, CA) was done by quantitating Ly6G+CD11b+ cells 
stained with Pacific Blue
TM
 anti-mouse CD11b and APC anti-mouse Ly6G (Clone 1A8) 
antibodies (Biolegend, San Diego, CA). Mincle expression was examined by using a rat 
anti-mouse Mincle monoclonal antibody (Clone 6G5, InvivoGen, CA) followed by goat 
anti-rat Alexa-488 secondary antibody (InvitroGen, OR). FlowJo (Tree Star) software 
was used to analyze all data.  
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Bacterial phagocytosis by neutrophils 
Bacterial phagocytosis of WT and Mincle
-/-
 neutrophils was assessed by flow cytometry. 
For this peritoneal neutrophils were isolated using an established model of thioglycollate-
induced peritonitis. Sterile 4% thioglycollate was injected in peritoneal cavity of mice 
and neutrophils enriched 8-12h following the injection were isolated (95-99% pure as 
assessed by flow cytometry using GR1 and CD11b antibodies). Neutrophils were 
incubated with GFP-labeled KPn (kindly provided by Dr. Steven Clegg, University of 
Iowa) for 1 hour and washed three times with ice-cold FACS-buffer (PBS+10% fetal 
bovine serum). Fluorescence of the attached but non-internalized bacteria was quenched 
by treating the cells with 0.04% Trypan Blue. The % positive cells containing fluorescent 
bacteria were determined by flow-cytometry using uninfected neutrophils as control.  
Neutrophil NETs 
For detection of neutrophil NETs in-vivo, the bronchoalveolar lavage (BAL) was 
performed in WT and Mincle
-/-
 mice at 3dp.i.. The lavage cells were cytocentrifuged on 
glass slides and were co-stained with Sytox Green (Molecular Probe, Eugene, OR) and 
rabbit anti-neutrophil elastase (NE) polyclonal antibody (abcam, ) followed by goat anti-
rabbit Alexa546 antibody. The percent NET formation was quantitated by dividing the 
number of NET-forming neutrophils by total number of cells in 8-10 random microscopic 





Statistical analysis of survival studies was performed by Kaplan Meir log-rank test; 
bacterial burdens by non-parametric Mann-Whitney Test. All other statistical analyses 





Mincle is highly expressed in lungs during pneumonic KPn infection.  
To examine the role of innate immune receptors in pathogenesis of KPn induced 
pneumonic sepsis, we initially screened  a panel of 52 membrane-bound and soluble 
CLRs by Taqman Low-density arrays which showed  an upregulated expression of 
Dectin-2 family CLR, Clec4e (also called Mincle), among others in the lungs of mice 
undergoing respiratory KPn infection. To further confirm the Mincle expression, real-
time quantitative PCR was performed using RNA from lungs of KPn infected wild-type 
mice. The results showed a progressive increase in the transcript level of Mincle mRNA 
which was maximally transcribed by 3dp.i. and remained at high level throughout the 
course of infection (Figure 17A).  Flow cytometry analysis further confirmed the 
increased numbers of Mincle-positive cells, majority of which were CD11b+Ly6G+ 
neutrophils, in the lungs of KPN-infected mice (Figure 17B). This indicated that Mincle 
was highly expressed on neutrophils and played a role in pathogenesis of KPn 
pneumonia.  
Mincle deficient mice are highly susceptible to KPn pneumonia.  
To examine the role of Mincle in disease development, overall disease severity and 
survival was compared in wild-type and Mincle
-/-
 mice infected with a sub-lethal dose of 
KPn. This dose was experimentally determined at which the WT mice displayed minimal 
morbidity and mortality [3]. As shown in Figure 17C, 76% of WT mice infected with 
2.5x10
4




positive cells were gated and further analyzed for expression of CD11b and Ly6G as 
mentioned in the Methods section. The dot plots shown are representative of 
3independent experiments with 3 mice each. C. Fifteen each WT and Mincle
-/-
 mice were 
intranasally infected with 2.5X10
4
 CFUs of Klebsiella pneumonia (KPn) in 20µl of sterile 
PBS and were assessed daily for disease severity. The survival was monitored for two 
week. Statistical comparison of susceptibility was done by Kaplan-Meier survival curve 
statistical analysis (p<0.001).  
lethargy) early during infection and appeared healthy later. The Mincle
-/-
 mice, in 
contrast, were extremely susceptible to this dose and all mice succumbed to infection by 
day 6p.i. While majority of the infected WT mice cleared the infection by day 5 p.i., 
Mincle
-/-
 mice exhibited progressive development of disease and overt signs of infection 
(weight loss, piloerection, hunched gait, lethargy, increased respiratory rate). The 
increased susceptibility of Mincle
-/-
 mice clearly indicated a protective role played by this 
CLR during pneumonic KPn infection. 
Mincle deficiency results in increased bacterial burden and systemic disseminatio 
In order to examine if increased susceptibility of Mincle
-/-
 mice to KPn infection 
correlated with inefficiency to clear bacteria, homogenized lungs, liver and blood from 
infected Mincle
-/-
 and WT mice collected at various times post infection were plated on 
LB agar. Up to 2dp.i., Mincle
-/-
 and WT animals displayed similar bacterial burdens in 
their lungs (Figure 18A). By 3dp.i., however, lungs of Mincle
-/-
 mice exhibited 





Figure 17. Mincle is highly induced in the lungs of KPn infected pneumonic mice 
and Mincle deficiency increases susceptibility to the infection.  
A. Total RNA was extracted by Trizol method from the lungs of KPn infected wild-type 
C57/BL6 mice, harvested at indicated time post-infection. The mRNA levels of Mincle 
were analyzed by real-time PCR as described in Methods and are expressed as fold 
changes over the levels in mock control mice calculated by using the formula 2
−(ΔΔCt)
. 
Data shown are the averages of 6-8 mice per group in two independent experiments. B. 
Mincle expression was examined on infiltrating lung cells from KPn infected wild-type 
C57/BL6 mice harvested at 3dp.i. by flow cytometry using a rat anti-mouse Mincle 




burden in these mice remained high at 5dp.i., the time when majority of mice had become 
moribund. In contrast, the WT mice displayed 3-5 logs lower bacterial burden at 3dp.i. 
and the counts continued to drop through 5dp.i., indicating clearance of bacteria and 
resolution of the infection in these mice. The Mincle
-/-
  mice also displayed a higher 
systemic dissemination of bacteria as depicted by significantly higher bacterial load in 
liver (Figure 18B) and a more severe bacteremia (Figure 18C). In contrast, no viable 
bacteria were detected in the blood of WT mice by 5dp.i. These data indicated that 




 mice exhibit hyperinflammatory response 
We next examined if the inability of Mincle
-/-
 mice to clear the bacteria was due to a 
defect in mounting inflammatory response. In both WT and Mincle
-/-
 strains, mock 
infected mouse lungs displayed similar low basal levels of inflammatory cytokines tested 
(Figure 19). Upon KPn infection, WT mice exhibited increased levels of these cytokines 
at 1dp.i., which started to drop by 3dp.i. and were reduced to minimal levels by 5dp.i. 
(Figure 19). This was consistent with the reduced bacterial burden in these mice at these 
times p.i..  In contrast, infection of Mincle
-/-
 mice resulted in a progressive increase in 
levels of these cytokines through the course of infection, which remained high till the 
mice became moribund.  These mice in fact exhibited an overwhelming inflammatory 
response at 3d and 5dp.i. (Figure 19). The levels of inflammatory cytokines and 
chemokines tested in lungs of these mice were significantly higher than WT mice at these 







 mice display increased bacterial burden and systemic 
dissemination during pneumonic KPn infection.  
WT and Mincle
-/-
 were intranasally infected with 2.5X10
4
 CFUs of KPn. At indicated 
times post infection the mice were sacrificed, systemic organs were isolated, 
homogenized and plated as described in Materials and Methods. Bacterial burden was 
enumerated after incubating the plates overnight at 37
o
C.  The data shown is from three 
independent experiments with 3-5 mice at each time point per experiment. Significant 
differences in bacterial burden (using non-parametric Mann-Whitney test) in WT and 
Mincle
-/- 




time points. The levels of IL-10, an anti-inflammatory cytokine were also significantly 
higher in Mincle
-/-
 mice, suggesting a condition of “cytokine storm” typical of sepsis, 
where anti-inflammatory host mediators are upregulated in an attempt to counter-balance 
the systemic inflammatory response [171-173]. These results show that Mincle 
deficiency did not render the mice defective in their ability to mount an inflammatory 
response but these mice rather displayed a hyperinflammatory phenotype typically 
associated with sepsis. Our observations thus raised the possibility that Mincle likely 
plays a direct role in bacterial clearance and the hyperinflammation resulted due to 
activation of other PRRs and inflammatory receptors in response to persistent 
overwhelming bacterial burden in Mincle
-/-
 mice undergoing pneumonic KPn infection. 
Effect of Mincle deficiency on neutrophil infiltration and overall lung pathology 
Since neutrophils are a key cell type involved in bacterial clearance and initiation of 
protective immune response during KPn pneumonia, we next compared neutrophil 
infiltration and gross immunopathological changes in KPn infected WT and Mincle
-/- 
mice. The mock control mice of both strains displayed similar normal lung tissue 
morphology in H&E stained sections (Figure 20). A moderate transient infiltration of 
immune cells was observed substantially by 5dp.i. The overall architecture of the lungs 
was largely preserved in the WT animals throughout the infection. The Mincle
-/-
 mice, on 
the other hand, displayed a progressive increase in immune cell infiltration, which were 
mainly neutrophils, based on characteristic multi-lobed nuclei (Figure 20 inset). By day 3 





Figure 19. Pneumonic Mincle
-/- 
mice exhibit hyperinflammatory response.  
The lungs from mock control and KPn infected WT and Mincle
-/-
 mice were harvested at 
indicated time points post-infection, homogenized in PBS with protease inhibitors and 
analyzed commercially for host immune mediators by rodent multi-analyte profile 
(Myriad
TM
 Rules-Based Medicine, Austin, TX). Results shown are average of 3-4 each 
infected and mock control mice from 3 independent experiments. Amounts of mediators 
shown were significantly higher (***p<0.001) in KPn infected Mincle
-/-
 mice at 3dp.i. 














































































































































































































influx of cells was observed in large lesions and by 5 p.i., extensive foci of consolidation 
were visible with massive accumulation of neutrophils around alveolar spaces (Figure 
20). Flow cytometry analysis of infiltrating cells in lungs confirmed that the majority of 
these cells were Ly6G+CD11b+ neutrophils (Figure 21A). The numbers of these cells 
were significantly higher in the infected Mincle
-/-
 lungs than those in the WT mice (Fig. 
21A, bar graph).  This correlated with significantly higher levels of neutrophil 
chemoattractants (CXCL1, CXCL6), neutrophil survival mediator (GM-CSF) and 
neutrophil activation markers (MMP9, MPO) in these mice, as compared to their WT 
counterparts (Figure 21B).  
 Mincle
-/-
 neutrophils are defective in KPn phagocytosis 
We next examined the bacterial uptake by Mincle
-/-
 neutrophils, in light of an increased 
bacterial burden in Mincle
-/-
 mice. For this, phagocytosis of GFP-labeled KPn was 
compared between WT and Mincle
-/-
 neutrophils by flow cytometry. As shown in Figure 
22, Mincle deficiency resulted in significantly reduced phagocytosis of non-opsonized 
bacteria by neutrophils. The uptake of opsonized bacteria was also reduced in Mincle
-/-
 
neutrophils as compared to the Mincle-sufficient WT cells, however the differences were 
not statistically significant. These results indicate that Mincle is likely a novel non-





Figure 21. Increased neutrophil accumulation coincides with elevated expression of 
neutrophil chemoattractant and activation markers in lungs of KPn infected Mincle
-
/-
 mice.     
A. Flow cytometry analysis of Ly6G+CD11b+ neutrophils in mock control (WT-M and 
Mincle
-/-
-M) and KPn infected (WT-Inf and Mincle
-/-
-Inf) WT and Mincle
-/-
 mice. Total 
lungs cells were isolated from mice by collagenase treatment at 3dp.i.. The cells were 
stained with anti-Ly6G-APC and anti-CD11b-Pacific Blue antibodies as markers for 
neutrophils. The bar graph shows average of total number of neutrophils in lungs of 2-3 
mock control and 3-4 KPn infected WT and Mincle
-/-
 mice each from 3 independent 
experiments. Dot plots shown on the right are from one representative experiment. 
Statistical significance are denoted by asterisks (***, p<0.001). B. The lungs from mock 
control and KPn infected WT and Mincle
-/-
 mice were harvested at indicated time points 
post-infection and analyzed commercially for host immune mediators by rodent multi-
analyte profile (Myriad
TM
 Rules-Based Medicine, Austin, TX). Levels of neutrophil 
chemoattractants (CXCL2, CXCL6, GM-CSF) and activation markers (matrix 
metalloproteinase 9, MMP-9 and myeloperoxidase, MPO) shown are average of 3-4 each 
infected and mock control mice from 3 independent experiments. Amounts of mediators 
shown were significantly higher (***p<0.001) in Mincle
-/-
 mice at 3dp.i. and 5dp.i. in 









Figure 22. Mincle deficiency impairs neutrophil phagocytosis of non-opsonized 
bacteria.  
Peritoneal neutrophils from WT and Mincle
-/-
 mice were incubated with GFP (Green 
Fluorescent Protein)-labeled KPn with (opsonized) or without (non-opsonized) 10% 
normal mouse serum for 1 hour followed by quantitation of phagocytosis by flow 
cytometry. The results are expressed as % cells positive for fluorescent bacteria.  






 neutrophils are defective in NET formation 
Extracellular trap formation is an important mechanism by which neutrophils clear 
extracellular bacteria. Since Neutrophil NET mediated killing has been shown to play a 
role in KPn clearance [156,174], we saught to determine if Mincle deficiency resulted in 
a defect in NET formation. In order to minimize the tissue processing to avoid 
degradation of NETs, neutrophils isolated from BAL were used. Flow cytometry analysis 
showed that neutrophils were a predominant cell-type in the BAL of infected WT and 
Mincle
-/-
 mice (Figure 23A). A quantitative comparison of BAL neutrophils showed that 
significantly higher numbers Mincle sufficient WT neutrophils produced NETs 
(Figure23B) which stained positive for neutrophil-specific enzyme neutrophil elastase 
(Figure 23C), showing that these fibrillar structures originated mainly from neutrophils. 
Furthermore, the NETs observed in Mincle
-/-
 neutrophils appeared dwarfed and lacked 
the web-like appearance as observed in the WT mice. This observation, together with 
phagocytic ability of Mincle
-/-
 neutrophils shows that Mincle deficiency severely impairs 
neutrophil mediated bacterial uptake and clearance mechanisms in lungs during 




Figure 23. Mincle deficiency causes a defect in formation of neutrophil extracellular 
traps (NETs) in the lungs of mice upon pneumonic KPn infection.    
A. Enumeration of CD11b+Ly6G+ neutrophils by flow cytometry in BAL isolated from 
KPn infected WT and Mincle
-/-
 mice. B. Quantitation of neutrophils showing NETs in 
BAL isolated from WT and Mincle
-/- 
mice infected with KPn. (***p<0.001). C. 
Representative fluorescence images of the neutrophils isolated from BAL fluid of WT 
(upper panel) and Mincle
-/-
 (lower panel) mice infected with KPn, and stained with Sytox 
Green to label DNA (green) and a rabbit anti-neutrophil elastase (NE) polyclonal 
antibody followed by goat anti-rabbit Alexa546 (red). The neutrophils from WT mice 
showed web-like structures that stained positive for NE and Sytox green (white arrow), 
while the Mincle-/- neutrophils appeared inactive and displayed occasional small DNA 
fibers that lacked the typical web-like appearance of NETs (blue arrow). The experiment 








Pneumonic sepsis is a major health care burden worldwide and K. pneumoniae (KPn) is 
the most frequent Gram-negative sepsis-associated opportunistic pathogen [155]. An 
imbalance of innate immune responses resulting in deleterious and prolonged 
inflammation and impairment of protective functions of first responder cells such as 
neutrophils have been directly correlated with sepsis-associated mortality [26,175,176]. 
This warrants an improved understanding of functioning of innate immune components 
in this deadly disease. In this study, we sought to determine the role of Mincle, an innate 
immune C-type lectin receptor in KPn pneumonia. Here we report several novel findings: 
1) We show, for the first time, a clear phenotype in terms of a severely reduced survival 
rate of Mincle
-/-
 mice  upon pneumonic KPn infection; 2)  the reduced survival is not due 
to a defect in ability to mount an inflammatory response in absence of Mincle; 3) Mincle 
acts as a non-opsonic phagocytic receptor mediating uptake of KPn by neutrophils; and 
4) Mincle deficiency results in a defect in neutrophil NET formation upon KPn infection.  
Our results  thus show that Mincle is required for defense against KPn induced 
pneumonic sepsis and that lack of Mincle causes a defect in neutrophil mediated bacterial 
clearance mechanisms such as phagocytosis and NET formation.  
Mincle has been previously shown to play a role in eliciting inflammatory responses 
against Mycobacterium, Candida albicans and skin fungal pathogens, Malassezia and 
Fonsecaea [165,177-179]. In these infections, Mincle expressed on macrophages, upon 
recognition of its ligands triggers FcRγ-Syk-Card9 pathway to induce production of 





inflammatory cell types [164,178,180].   The increased susceptibility to these infections 
in the absence of Mincle was measured in terms of increased bacterial and fungal burden 
which was attributed to reduced inflammatory response and defective pathogen clearance 
in these studies. However, overall survival of the experimental animals was not affected 
by Mincle deficiency. Our study for the first time, reports a clear outcome where Mincle 
seems to play a non-redundant role in survival of KPn infected pneumonic mice. 
Moreover, the reduced survival of Mincle
-/-
 mice is not due to their inability to mount an 
inflammatory response. These mice, instead exhibit  hyperinflammation in their lungs 
suggesting that the protective ability of Mincle was independent of its role in eliciting 
inflammatory response. It is likely that the redundant function of other PRRs, upon 
recognition of bacterial PAMPs and endogenous alarmins generated from increased 
bacterial growth and accumulation of dead cells over time, is sufficient to induce 
inflammation in the absence of Mincle. Indeed, Mincle
-/-
 mice in our studies, exhibited 
overwhelming local as well as systemic bacterial burdens.  
Concomitant to increased bacterial burden, Mincle
-/-
 mice exhibited extensive neutrophil 
accumulation, the primary cell type shown to play an important role in mediating 
protective immune response against Kpn infection [117,126,138,181]. We thus examined 
if Mincle
-/-
 neutrophils were defective in performing cellular functions such as 
internalization of bacteria via phagocytosis which would explain increased bacterial 
burden in Mincle
-/-
 mice despite a heightened inflammation. Indeed, Mincle
-/-
 neutrophils 
showed a mitigated phagocytosis of non-opsonized, but not opsonized KPn, suggesting a 
non-redundant and direct role of Mincle for internalization of non-opsonized bacteria. To 




phagocytic receptor. Ongoing studies in our lab are currently investigating Mincle 
specific ligand of KPn, nature of this interaction and production of specific antibodies 
that can inhibit this interaction.   Lectinophagocytosis or lectin-mediated uptake by 
macrophages has been reported previously for several pathogens (reviewed in [182]. 
However, the receptors or mechanisms of non-opsonized phagocytosis of bacteria by 
neutrophils are poorly understood. Non-opsonic phagocytosis by receptors like Mincle 
may be important during early stages of infection before the onset of humoral immunity 
to generate opsonins, and in complement deficient or immunosuppressed patients. This 
mode of phagocytosis is particularly significant for inhaled bacteria as serum and 
complement components are as such limited in the alveolar space [183]. Although 
appearance of serum components in alveolar space is common during severe KPn 
pneumonia, owing to high binding capacity of Mincle to mannose and N-
acetyleglucosamine [184], uptake by Mincle of KPn with mannan-rich capsule in lungs 
could be a major mechanism of bacterial clearance in lungs.  Absence of Mincle and a 
resulting defect in initial phagocytic uptake of KPn, as observed in our studies likely 
contributes to the increased bacterial burden and subsequent inflammation via activation 
of other PRRs such as TLRs.  
One of the more recently defined mechanisms of antimicrobial activity of neutrophils is 
extrusion of fibrous mesh of chromatin that entraps extracellular pathogens [166]. These 
structures, termed NETs, are decorated with antimicrobial factors normally contained 
within neutrophil granules and represent an important strategy of neutrophils to 
immobilize and kill pathogens. Our observation reported in this study that Mincle
-/-
 




overwhelming bacterial burdens in these mice. These results are in line with previous 
reports indicating that NET mediated killing is an important mechanism of bacterial 
clearance and protection against KPn induced pneumonia [156,174]. How Mincle 
regulates NET formation is currently under investigation in our laboratory and is 
expected to provide novel insights into mechanism of NETosis. This will have important 
implications in chronic disease conditions where deregulated NET formation is 
associated with the pathophysiology.   
Taken together, our results show that Mincle plays a protective role in KPn induced 
pneumonic sepsis by regulating neutrophil phagocytosis and NET formation, two 
important mechanisms of antimicrobial activity of neutrophils. Particularly, the novel 
observation of Mincle as a potential new component of NETosis pathway implicates this 
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Sepsis is a complex immune disorder that results in 750,000 hospitalizations annually in 
the United States alone [185]. Pulmonary infections, in turn, are a major cause of sepsis 
[5]. In addition to posing an immense health hazard with a mortality rate of 20-50%, it is 
also a huge economic healthcare burden with the patients consuming half of the ICU 
resources in the country. In October 2011, the only FDA approved drug for the treatment 
of sepsis (Xigris) was withdrawn from market following the much anticipated results of 
the clinical trial (PROWESS-SHOCK) where it failed to show any survival benefit for 
severe sepsis and septic shock patients [186]. As a result we are now left with no 
effective preventive or treatment options for this deadly immune disorder. As clinical 
presentations of sepsis are known to be caused by an unbridled hyper-inflammatory 
responses causing massive tissue pathology leading to multiple organ failure [23,28], our 
major goal was to identify mechanisms responsible for pulmonary infection-induced 
sepsis development. In this regard, most of the sepsis research has been focused on 
initiation of inflammatory response upon pathogenic insult and the role of pathogen 
associated molecules or PAMPs [28]. However, our earlier studies with Francisella, a 
Gram-negative pathogen, demonstrated that pulmonary infection with this bacterium 
leads to development of severe sepsis and systemic organs failure despite absence of any 
bacterial toxins [73,78,80]. Moreover, LPS which is the major PAMP in Gram negative 
bacterial pathogens, is modified in Francisella and as a result, does not stimulate 




shown that extensive tissue damage is a hallmark of sepsis, our initial hypothesis was that 
endogenous molecules released from the dead or dying cells contribute and/ or exacerbate 
the host inflammatory response culminating in sepsis development. Thus, our first goal 
was to identify novel self-molecules termed as alarmins that are released from dead/dying 
cells and their role to regulate induction and/ or exacerbation of host inflammatory 
response. An efficient recognition and clearance of the damaged cells by efferocytosis is 
essential to prevent inflammatory response due to PRR-alarmin interaction. Thus, 
efferocytosis is an important step for resolution of inflammation and maintenance of 
normal body physiology. Therefore, our second goal was to identify novel host cell 
surface receptors involved in efferocytosis.  In this regard, the importance of the lectins in 
host immunity and homeostasis has been demonstrated in several recent studies in 
different clinical settings [55,56]. Lectins are involved in recognition of glycan structures 
on a wide range of antigens [188], including cryptic self-antigens that are exposed by cell 
death or are modified during disease conditions, leading to inflammation [189]. In 
contrast, studies have also shown that lectins mediated recognition and sampling of self-
glycan antigens ensures a state of immune tolerance helping to maintain normal body 
physiology. Indeed, it has been established that lectins are important biological regulators 
in eliciting immune suppression [190-193]. Owing to such dual functions of lectins in 
induction as well as resolution of inflammation in various clinical settings, here we 
focused to characterize lectins that can function as novel alarmin or alarmin receptor to 





Lectins as novel alarmins and their function in induction/ exacerbation of 
hyperinflammatory response in pneumonic sepsis: role of galectin -3 and -9 
Extracellular presence and induction of inflammation 
Alarmins: a) are endogenous molecules typically perform homeostatic functions when 
contained within cellular compartments; b) can be found extracellularly despite lacking 
any signal sequence for active secretion; c) have chemoattractant and immune activating 
properties; and d) exhibit immune enhancing properties when injected in-vivo 
[26,29,30,84]. Galectins constitute the only soluble mammalian lectins which do not 
contain any secretion signal sequence [66]. Consistent with the property of alarmins, 
galectins play homeostatic roles [63]. We first analyzed the expression and distribution of 
galectins 1-13 in uninfected and Francisella infected lung tissues. Francisella infection 
was found to upregulate the expression of many galectins including galectin-3 and 
galectin-9. Interestingly, out of all galectins tested, only galectin-3 and galectin-9 
exhibited extracellular presence. Such upregulated and extracellular expression suggested 
possible alarmin functions for these molecules in infection and pathological processes 
[63,64,66,137] associated with sepsis. As alarmins can induce and/or exacerbate 
inflammatory responses from myeloid cells such as macrophage and neutrophils that are 
typically associated innate immune responses, effect of galectin-3 and -9 on these cells 
was examined. Purified recombinant galectin-3 and -9 exacerbated F. novicida-induced 
production of the inflammatory mediators by macrophages and neutrophils.  
Notwithstanding the mechanisms involved in the disparity of inflammatory mediators 
induction by recombinant galectin-3 and -9 alone, clearly both these molecules 




involving a prototype alarmin HMGB1 have also reported that while HMGB1 by itself 
failed to induce inflammatory mediators in macrophage, it exacerbated agonist-induced 
inflammatory mediator productions [31,32]. Increased extracellular release of galectin-3 
and -9 in Francisella infected lungs, and their ability to increase production of 
inflammatory mediators likely is the primary contributor to the tissue damage observed 
during pulmonary Francisella infection-induced sepsis.  
Inflammation and disease phenotype in vivo: 





 mice were analyzed for overall disease 
pathogenesis. As both galectin-3 and -9 exposure enhanced development/ exacerbation of 
infection induced inflammation in myeloid cells in vitro, we speculated that in the 
absence of galectin-3  and galectin-9 Francisella-infected mice would display reduced 
systemic inflammation. Indeed these mice showed a reduced level of inflammatory 
mediators, including multitude cytokines and chemokines, many of them markers of 
sepsis. Additionally, a reduced number of neutrophils in lungs after Francisella infection 




 mice. The results further suggest a key 
role for galectin-3 and galectin-9 as critical modulators of inflammatory response during 
bacteria induced murine sepsis. Since these mice also display decreased systemic tissue 
pathology, the results are consistent with alarmin properties playing a role in 
exacerbating inflammation induced tissue pathology which is detrimental to host in 




mice exhibit improved survival, these infected mice eventually succumbed to infection 




possible that, high bacterial burden contributes to increased cell death, albeit at a lower 
level as compared to the corresponding WT mice, leading to an increased accumulation 
of other alarmins which eventually mask the advantageous effect of the absence of 
galectin-3 and -9. Thus persistence of alarmins released by the damaged tissue and 







Our findings indicate that both galectin-3 and -9 function as novel alarmins and play a 
pathogenic role to exacerbate the inflammatory response during pulmonary infection with 
Francisella and contributes to sepsis development. Galectin-3 and -9 thus may represent 
combinatorial potential target/s for treatment of sepsis. 
Lectins in resolution of inflammation: role of Clec4d 
Sepsis is now perceived as interplay of PAMPs (non-self) and alarmins (self) over-
activating immune cells leading to an unbridled inflammatory response. As discussed in 
the introduction section, our laboratory and others have clearly demonstrated that massive 
cell death is a hallmark of sepsis [29,30,78]. Results from the present study discussed 
above together with other studies have established the pathogenic role of alarmins, that 
can be passively secreted from dead cells, in immunopathology of sepsis. In this regard, 
an understanding of the functioning of host innate immune components likely acting as 
receptors for alarmins released from dead cells or dead cells is critical. Here, our results 
clearly show that Clec4d deficiency, in an otherwise sublethal pulmonary bacterial 




correlated with increased mortality of the infected Clec4d
-/-
 (KO) mice. Interestingly, the 
KO mice displayed a massive accumulation of neutrophils in their lungs. Despite this, an 
increase in local as well as systemic bacterial burden was observed in these KO mice. 
This was not likely due to a dysfunction of neutrophils as bacterial uptake and killing by 
neutrophils was found to be unaffected in the KO neutrophils. Thus, we propose that 
persistent accumulation of neutrophils and their associated inflammatory response in 
lungs likely contributed to tissue destruction as well as inflammation inducing tissue 
pathology observed in the KO mice. Accumulation of large numbers of neutrophils in the 
lungs of KO mice and higher amounts of their associated inflammatory mediators suggest 
that there is a defect in neutrophil turnover in these mice. It is thus possible that Clec4d 
plays an important role in mitigating the inflammation during a pneumonic infection, by 
facilitating neutrophil turnover.  
Neutrophil-mediated responses are essential for combating pneumonic bacterial infection, 
and their protective role in sepsis and KPn infection, in particular, has been described 
elegantly. However, neutrophils that have infiltrated to the affected site are readily 
cleared to prevent bystander tissue destruction, owing to their tissue-destructive cargo.  
Indeed, to restore the quiescent state of homeostasis, clearance of infiltrating immune 





Figure 24. Impaired efferocytosis of uninfected Clec4d
-/- 
neutrophils by murine J774 
macrophages.  
CFSE-labelled dead neutrophils from WT and Clec4d
-/- 
mice were incubated with J774 
macrophages at a ratio of 10:1 for 1h at 37⁰C. Flow cytometry was performed and 




efferocytosis which not only prevents the potential tissue damage caused by alarmins 
released from dead/dying cells but also leads to production of specialized lipid mediators 
by efferocytic cells which promote tissue repair [194-196]. Not surprisingly, a defective 
efferocytosis has been implicated in several acute and chronic inflammatory lung 
diseases (reviewed in [197]. We thus speculated that Clec4d plays a protective role in 
pulmonary KPn induced sepsis by mediating efferocytosis which resolves inflammation 
as well as aids in bacterial clearance. ). Indeed, our preliminary results (presented here) 
shows that Clec4d
-/-
 neutrophils are not efferocytized efficiently (Fig.24). Furthermore, 
Clec4d-mediated uptake of KPn-infected neutrophils by macrophages aids in control of 
infection (data not shown). Thus, we propose that Clec4d-mediated clearance of infected 
neutrophils is critical for successful elimination of a pathological insult. Furthermore, 
Clec4d-mediated efferocytosis of infected neutrophils and dead neutrophils and their 
contents is important in mitigating the inflammation during a pneumonic infection. This 
study opens up new avenues of research on the role of Clec4d in the resolution of 
inflammatory responses. This can have major implications in the therapeutic 
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